syndrome	score	normalized_score
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	2.010735944	100.0
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	1.1455937999999999	56.973855936600295
SPINOCEREBELLAR ATAXIA TYPE 20	1.1227388999999999	55.837212407239875
NETHERTON SYNDROME; NETH	1.071974154	53.31252754488981
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	1.0714286	53.28539548900609
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	50.59172603123267
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	50.59050160392419
SENGERS SYNDROME	1.00684932	50.073671931136474
OCULOSKELETODENTAL SYNDROME; OCSKD	1.000545554	49.76016651940848
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	49.73303446352477
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	49.73303446352477
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	46.41748225494496
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.667212554	33.182504942578376
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.590545224	29.369605977461955
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.5555556	27.629465801204184
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.546756484	27.191859061927627
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.5448995	27.099505612657417
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	0.5324612	26.48091121008975
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.516030184	25.663746925091026
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.514244154	25.574922233548136
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.501301984	24.931268846905343
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.50075643	24.904136791021628
XYLT1-CDG	0.50075643	24.904136791021628
%109160 AZOTEMIA, FAMILIAL	0.5	24.866517231762383
BARTH SYNDROME; BTHS	0.5	24.866517231762383
BRANCHIOOTORENAL SYNDROME 1	0.5	24.866517231762383
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.5	24.866517231762383
PITT-HOPKINS-LIKE SYNDROME	0.5	24.866517231762383
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.5	24.866517231762383
GLYCINE ENCEPHALOPATHY	0.5	24.866517231762383
RENAL TUBULAR ACIDOSIS III	0.5	24.866517231762383
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.4787875	23.81155523820486
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.458151304	22.785254591340813
GLUTATHIONE SYNTHETASE DEFICIENCY	0.37914580000000003	18.85607113810067
SPINOCEREBELLAR ATAXIA TYPE 12	0.3657942	18.19205555515747
POSTENCEPHALITIC PARKINSONISM	0.3619044	17.998603997701252
ACUTE ADRENAL INSUFFICIENCY	0.35369827	17.590488251599087
INSULINOMA	0.35264303	17.5380079643118
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.348584754	17.336177584141303
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.345506454	17.183084384152238
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3449609	17.155952328268523
ADDISON DISEASE	0.33999967	16.90921530569705
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.33791922999999996	16.80574871147775
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.33463498399999997	16.642413191973056
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.334295624	16.62553578939752
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333878554	16.604793632713815
EPIDERMAL NEVUS SYNDROME	0.333878554	16.604793632713815
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333333	16.5776615768301
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	16.5776615768301
CANAVAN DISEASE	0.333333	16.5776615768301
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	16.5776615768301
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	16.5776615768301
NEUROMYELITIS OPTICA	0.333333	16.5776615768301
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.333333	16.5776615768301
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333333	16.5776615768301
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.333333	16.5776615768301
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	16.5776615768301
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.32152769999999997	15.990548185077852
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.31721225399999997	15.775927960434371
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	15.196207185322988
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	14.919910339057433
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.28678662	14.26276885613778
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.285028354	14.175324952563736
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	13.81474284720898
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27446538000000004	13.649996202584422
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.273146554	13.584406983675029
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.265251454	13.191759703282054
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.265000584	13.179283176926191
CITRULLINEMIA TYPE II	0.264082984	13.13364814450246
HSD10 DISEASE	0.25473841399999997	12.668914322645639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.251301984	12.498010231024148
AL KAISSI SYNDROME; ALKAS	0.251301984	12.498010231024148
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	12.490421765693565
BIOTINIDASE DEFICIENCY	0.250545554	12.460390671764905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.250545554	12.460390671764905
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.250545554	12.460390671764905
DYSTONIA 6, TORSION	0.25	12.433258615881192
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	12.433258615881192
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	12.433258615881192
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.433258615881192
HYPERPARATHYROIDISM 2	0.25	12.433258615881192
SPINOCEREBELLAR ATAXIA TYPE 18	0.24545450000000002	12.207197107727241
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.24545450000000002	12.207197107727241
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.22859747	11.368845853784569
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.2285714	11.367549313576106
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	11.076904486867821
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.22222199999999998	11.051774384553399
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.22010343000000002	10.946411469730013
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.216667	10.77550737810852
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.21526794999999999	10.705928376242326
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.214172374	10.651442057276915
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.212929884	10.58964925928633
ANGELMAN SYNDROME	0.21259375400000002	10.572932494412107
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.207394874	10.314376416200377
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20419286	10.155130543585688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.20130198400000002	10.011358507847913
SPINOCEREBELLAR ATAXIA TYPE 13	0.20054555400000001	9.973738948588668
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	9.973738948588668
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.20054555400000001	9.973738948588668
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.20054555400000001	9.973738948588668
JUVENILE HYALINE FIBROMATOSIS	0.2	9.946606892704954
BETA-THALASSEMIA	0.2	9.946606892704954
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	9.946606892704954
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	9.946606892704954
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	9.946606892704954
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	9.946606892704954
POLYARTERITIS NODOSA	0.2	9.946606892704954
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	9.946606892704954
MEDULLARY SPONGE KIDNEY	0.2	9.946606892704954
SHOX-RELATED SHORT STATURE	0.2	9.946606892704954
6P22 MICRODELETION SYNDROME	0.2	9.946606892704954
BENIGN SCHWANNOMA	0.2	9.946606892704954
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	9.946606892704954
INFANTILE MYOFIBROMATOSIS	0.2	9.946606892704954
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.2	9.946606892704954
MALARIA	0.2	9.946606892704954
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	9.946606892704954
SPINOCEREBELLAR ATAXIA TYPE 42	0.1851369	9.207419828170138
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.18329603	9.11586777701727
HEREDITARY FRUCTOSE INTOLERANCE	0.1770837	8.806909755028482
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.171000434	8.504370477399693
MUCOLIPIDOSIS TYPE II	0.166667	8.288855654932282
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	8.288855654932282
DERMATOLEUKODYSTROPHY	0.166667	8.288855654932282
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	8.288855654932282
CEREBROOCULONASAL SYNDROME	0.166667	8.288855654932282
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.16178655	8.046136066884772
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.16165175400000004	8.03943225277123
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.15796865400000001	7.856260513538619
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.1565655	7.786477407298986
SPINOCEREBELLAR ATAXIA TYPE 28	0.1565655	7.786477407298986
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.1559114	7.753947029456396
GITELMAN SYNDROME	0.14545450000000001	7.233893661374764
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.14052279999999998	6.988625255310997
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.13970847	6.9481261533563154
SPINOCEREBELLAR ATAXIA TYPE 2	0.1319443	6.56199041916565
DYSTONIA 16; DYT16	0.1319443	6.56199041916565
PULMONARY ARTERIOVENOUS MALFORMATION	0.1266234	6.2973659160886815
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.1266234	6.2973659160886815
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.1266234	6.2973659160886815
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.1266234	6.2973659160886815
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	6.2973659160886815
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.125937454	6.263251740030565
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.12581689999999998	6.257256223793848
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.12313256000000002	6.123755850062032
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	6.043941292372898
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	6.043941292372898
GALACTOSEMIA	0.12152769999999999	6.043941292372898
PYRUVATE CARBOXYLASE DEFICIENCY	0.12110379400000001	6.022859160665604
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.119262304	5.931276275031368
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.118505874	5.893656715772123
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.112893094	5.614516134595942
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.11245416999999999	5.592687112177073
METHYLMALONIC ACIDURIA, CBLA TYPE	0.11243788400000003	5.591877159977801
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.112412984	5.5906388074196585
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.112412984	5.5906388074196585
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.112412984	5.5906388074196585
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.11186742999999999	5.563506751535944
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.11165655399999999	5.553019248160414
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.11165655399999999	5.553019248160414
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11165655399999999	5.553019248160414
RENAL AGENESIS, BILATERAL	0.11111099999999999	5.5258871922766994
BRUNNER SYNDROME; BRNRS	0.11111099999999999	5.5258871922766994
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	5.5258871922766994
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	5.5258871922766994
ENTERIC ANENDOCRINOSIS	0.11111099999999999	5.5258871922766994
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.11111099999999999	5.5258871922766994
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	5.5258871922766994
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	5.5258871922766994
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.11111099999999999	5.5258871922766994
PRIMARY DYSTONIA, DYT27 TYPE	0.11111099999999999	5.5258871922766994
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.11111099999999999	5.5258871922766994
PRIMARY DYSTONIA, DYT4 TYPE	0.11111099999999999	5.5258871922766994
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11096225400000001	5.51848960233239
FAMILIAL HYPOALDOSTERONISM	0.1104167	5.4913575464486755
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	5.4913575464486755
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.11016039999999999	5.478610969715674
METHYLMALONIC ACIDURIA, CBLB TYPE	0.10900145400000003	5.420973068356311
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.10817512000000001	5.379876971055928
SPINOCEREBELLAR ATAXIA 12	0.10795450000000001	5.368904868992585
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10721222400000001	5.331989231103138
OCULOCEREBRORENAL SYNDROME OF LOWE	0.10684932000000001	5.313940913964187
SILVER-RUSSELL SYNDROME	0.10620410000000001	5.281852165467631
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.1055556	5.249600292618035
BETA-KETOTHIOLASE DEFICIENCY	0.10530529	5.23715161676147
DILATED CARDIOMYOPATHY WITH ATAXIA	0.10383212	5.1638864023808395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.103082554	5.126608210670153
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.102537	5.099476154786439
MELAS	0.10141773000000003	5.043811461302451
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.10131615399999999	5.038759778593782
SAY SYNDROME	0.10075643000000001	5.010923005611721
HENNEKAM-BEEMER SYNDROME	0.10075643000000001	5.010923005611721
RABSON-MENDENHALL SYNDROME	0.10054555400000001	5.000435502236191
ACRAL PEELING SKIN SYNDROME	0.10034306000000001	4.990364861155534
INTESTINAL LYMPHANGIECTASIA	0.1	4.973303446352477
DRACUNCULIASIS	0.1	4.973303446352477
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	4.973303446352477
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	4.973303446352477
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	4.973303446352477
BEHÇET DISEASE	0.1	4.973303446352477
X-LINKED ACROGIGANTISM	0.1	4.973303446352477
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	4.973303446352477
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.1	4.973303446352477
LOWE OCULOCEREBRORENAL SYNDROME	0.1	4.973303446352477
ACQUIRED ICHTHYOSIS	0.1	4.973303446352477
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	4.973303446352477
ESOPHAGEAL ATRESIA	0.1	4.973303446352477
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	4.973303446352477
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0986081	4.904080035682696
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.09848841400000002	4.898127687719897
HISTIOCYTOID CARDIOMYOPATHY	0.09704222000000001	4.826204071676953
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.09662405399999999	4.805407407587477
PELIZAEUS-MERZBACHER DISEASE	0.09564751400000002	4.756841110112468
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.09562707399999999	4.755824566888032
GLYCEROL KINASE DEFICIENCY; GKD	0.094396624	4.694630554632389
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.09330630000000001	4.6404054335639815
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.09330630000000001	4.6404054335639815
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.09330630000000001	4.6404054335639815
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.09330630000000001	4.6404054335639815
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.09330630000000001	4.6404054335639815
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.09280117	4.6152837858654205
SPINOCEREBELLAR ATAXIA TYPE 36	0.09156520000000001	4.553815247259538
BARDET-BIEDL SYNDROME 1; BBS1	0.09145465400000001	4.5483174592317335
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.09145465400000001	4.5483174592317335
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.09145465400000001	4.5483174592317335
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.09145465400000001	4.5483174592317335
PONTINE TEGMENTAL CAP DYSPLASIA	0.09145465400000001	4.5483174592317335
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09092110400000002	4.521782398693721
MALIGNANT ATROPHIC PAPULOSIS	0.0909091	4.52118540334802
ARTERIAL TORTUOSITY SYNDROME	0.0909091	4.52118540334802
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0909091	4.52118540334802
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0909091	4.52118540334802
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.0909091	4.52118540334802
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0909091	4.52118540334802
13Q12.3 MICRODELETION SYNDROME	0.0909091	4.52118540334802
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0909091	4.52118540334802
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.0909091	4.52118540334802
ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT	0.0909091	4.52118540334802
VERNAL KERATOCONJUNCTIVITIS	0.0909091	4.52118540334802
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0909091	4.52118540334802
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.0909091	4.52118540334802
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09037555000000001	4.494650342810006
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	4.477882850240628
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.08791923	4.372490095596561
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08676973000000002	4.3153219724807395
INHERITED CREUTZFELDT-JAKOB DISEASE	0.08676973000000002	4.3153219724807395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.085784784	4.266337619118028
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.085784784	4.266337619118028
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.085028354	4.228718059858784
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.084995784	4.227098254926307
DERMATITIS, ATOPIC	0.08465044000000001	4.209923249872536
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08463528400000002	4.2091694960022075
RFT1-CDG	0.08463528400000002	4.2091694960022075
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.08408973000000002	4.182037440118493
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.08387885400000002	4.171549936742963
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.08387885400000002	4.171549936742963
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.08387885400000002	4.171549936742963
STORMORKEN SYNDROME; STRMK	0.08333330000000001	4.144417880859249
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	4.144417880859249
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.08333330000000001	4.144417880859249
DPM3-CDG	0.08333330000000001	4.144417880859249
LYSOSOMAL ACID LIPASE DEFICIENCY	0.08316865400000001	4.136229535666967
IMMUNODEFICIENCY 23; IMD23	0.08140811400000002	4.048672539172554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.08140811400000002	4.048672539172554
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.0810138	4.029062107421103
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.0810138	4.029062107421103
IGE RESPONSIVENESS, ATOPIC	0.08086256000000001	4.02154048328884
XP21 MICRODELETION SYNDROME	0.077313254	3.845022725669244
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.07581492000000001	3.7705060292093737
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.07512260000000001	3.736074854789586
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.07509375400000001	3.7346402556774514
WOLCOTT-RALLISON SYNDROME	0.0740898	3.684710576795657
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0740259	3.6815326358934386
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.07269885000000001	3.6155344125086177
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.072293704	3.5953852725278583
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07197415400000001	3.5794930813650394
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07197415400000001	3.5794930813650394
TEMPLE SYNDROME	0.07142860000000001	3.552361025481326
CHRONIC ACTINIC DERMATITIS	0.07142860000000001	3.552361025481326
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.07142860000000001	3.552361025481326
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	3.552361025481326
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07142860000000001	3.552361025481326
JUVENILE TEMPORAL ARTERITIS	0.07142860000000001	3.552361025481326
EOSINOPHILIC GASTROENTERITIS	0.07142860000000001	3.552361025481326
IMMUNODEFICIENCY 58; IMD58	0.07142860000000001	3.552361025481326
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07142860000000001	3.552361025481326
PGM3-CDG	0.07142860000000001	3.552361025481326
EOSINOPHILOPENIA	0.07142860000000001	3.552361025481326
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.070651304	3.513703736724965
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.069511154	3.4570006174813774
ALAGILLE SYNDROME 1; ALGS1	0.0692541	3.4442165420403903
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0689656	3.429868561597664
ATYPICAL WERNER SYNDROME	0.0689245	3.427824533881213
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	3.3155372886694665
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	3.3155372886694665
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.06628780000000001	3.2966934419112373
SPINOCEREBELLAR ATAXIA 27; SCA27	0.06628780000000001	3.2966934419112373
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.066007884	3.282772369836345
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06549017	3.2570248816320957
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.0647059	3.218020754693387
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.06325643	3.145934213229542
X-LINKED DYSTONIA-PARKINSONISM	0.0630542	3.135876701669984
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.0625	3.108314653970298
UROCANIC ACIDURIA	0.0625	3.108314653970298
DRAVET SYNDROME	0.0625	3.108314653970298
CARIBBEAN PARKINSONISM	0.0625	3.108314653970298
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.0625	3.108314653970298
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0625	3.108314653970298
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0625	3.108314653970298
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0625	3.108314653970298
HUNTINGTON DISEASE-LIKE 2	0.0625	3.108314653970298
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.0625	3.108314653970298
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0610326	3.035336399198522
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.060705954	3.019091302423149
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.06064805400000001	3.0162117597277116
VICI SYNDROME; VICIS	0.060125484	2.990222767908107
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059891624000000004	2.978592200468467
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.05957993	2.9630907120243934
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.059369054	2.952603208648863
TIGLIC ACIDEMIA	0.0588235	2.925471152765149
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	2.925471152765149
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	2.925471152765149
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	2.925471152765149
ACQUIRED METHEMOGLOBINEMIA	0.0588235	2.925471152765149
GAPO SYNDROME	0.0588235	2.925471152765149
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	2.925471152765149
VON HIPPEL-LINDAU DISEASE	0.0588235	2.925471152765149
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0588235	2.925471152765149
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	2.925471152765149
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	2.925471152765149
PSEUDOXANTHOMA ELASTICUM	0.0588235	2.925471152765149
3M SYNDROME	0.0588235	2.925471152765149
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.925471152765149
WERNER SYNDROME	0.0588235	2.925471152765149
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	2.925471152765149
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	2.925471152765149
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	2.925471152765149
MOYAMOYA DISEASE	0.0588235	2.925471152765149
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	2.925471152765149
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.925471152765149
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057173184	2.8433959302614427
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057173184	2.8433959302614427
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.057082400000000005	2.8388809664607066
WHITE-SUTTON SYNDROME; WHSUS	0.056857584	2.8277001845847543
HYDROXYKYNURENINURIA	0.056416754	2.805776371002199
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.7629485694417966
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.7629485694417966
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.7629485694417966
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0553161	2.751037507687782
TREMOR, HEREDITARY ESSENTIAL, 1	0.0553161	2.751037507687782
KEARNS-SAYRE SYNDROME; KSS	0.053253180000000004	2.648442236232288
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.052849374000000005	2.62835973851771
AMYLOIDOSIS	0.052139099999999994	2.593035657197164
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.05212117	2.5921439438892335
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.050545554	2.5137837790599518
PROPIONIC ACIDEMIA	0.050489524	2.5109972371389606
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.05	2.4866517231762386
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05	2.4866517231762386
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.049404699999999996	2.457045647760102
MULTIPLE SYSTEM ATROPHY	0.049404699999999996	2.457045647760102
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.049404699999999996	2.457045647760102
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.049404699999999996	2.457045647760102
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.049404699999999996	2.457045647760102
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04889093	2.431494306643777
PROPIONIC ACIDEMIA	0.048811034	2.4275208361222793
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.047076554	2.3412598825059847
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.047076554	2.3412598825059847
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.047076554	2.3412598825059847
CORNELIA DE LANGE SYNDROME 3	0.047076554	2.3412598825059847
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.046982824	2.3365984051857183
RHEUMATOID ARTHRITIS	0.0466532	2.3202052034337135
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.046531	2.314127826622271
VICI SYNDROME	0.046000054	2.287722270906
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0458153	2.2785338938567263
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0454545	2.2605902150222867
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	2.2605902150222867
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0454545	2.2605902150222867
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	2.2605902150222867
DYSTONIA 23; DYT23	0.0454545	2.2605902150222867
X-LINKED CENTRONUCLEAR MYOPATHY	0.0454545	2.2605902150222867
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	2.2605902150222867
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0454545	2.2605902150222867
ALAGILLE SYNDROME 2	0.0454545	2.2605902150222867
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0454545	2.2605902150222867
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0454545	2.2605902150222867
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	2.2605902150222867
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.04514826	2.2453599705481766
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.045129354	2.244419717798609
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.044462313999999996	2.2112457944900594
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.04420735399999999	2.198565860023239
NAVAJO NEUROHEPATOPATHY	0.043666274	2.1716563097357153
PRIMARY HYPEROXALURIA TYPE 1	0.0429832	2.1376849669525777
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.04227	2.102215366773192
AMISH INFANTILE EPILEPSY SYNDROME	0.04208855	2.0931913076697852
HYPOTONIA-CYSTINURIA SYNDROME	0.042070604	2.0922987986333026
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.041695024	2.073620065549492
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.04133212	2.055571748410541
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.04133212	2.055571748410541
GLYCOGEN STORAGE DISEASE 0, LIVER	0.04133212	2.055571748410541
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.0401993	1.999233172309571
SMITH-MAGENIS SYNDROME; SMS	0.040058354	1.9922235000340751
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.987764734562282
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.0397706	1.9779126204350583
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.03883152	1.9312093224310514
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.03863859	1.9216143280920035
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.038176843999999995	1.8986502983606084
GABRIELE-DE VRIES SYNDROME	0.03791923	1.885838372420322
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.037016284	1.8409321278836206
PYRIDOXINE-DEPENDENT EPILEPSY	0.036591533999999995	1.8198080214952381
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.036566124	1.81854430508952
VASCULAR EHLERS-DANLOS SYNDROME	0.036259854	1.8033125686243763
OCULOECTODERMAL SYNDROME; OES	0.036259854	1.8033125686243763
THUMBS, CONGENITAL CLASPED	0.0361093	1.7958250613537545
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.03607847	1.7942917919012444
NEURONAL CEROID LIPOFUSCINOSIS	0.03604598	1.7926759656115243
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	1.7926759656115243
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.03602057	1.7914122492058064
PIERPONT SYNDROME	0.035784784	1.7796858959417898
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.035784784	1.7796858959417898
OROFACIODIGITAL SYNDROME TYPE 14	0.035784784	1.7796858959417898
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.035784784	1.7796858959417898
CEREBROFACIOARTICULAR SYNDROME	0.035784784	1.7796858959417898
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.035784784	1.7796858959417898
CONGENITAL DISORDER OF GLYCOSYLATION	0.035783624	1.779628205621812
SOTOS SYNDROME	0.035783624	1.779628205621812
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.035714300000000004	1.776180512740663
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	1.776180512740663
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	1.776180512740663
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.035714300000000004	1.776180512740663
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.035714300000000004	1.776180512740663
FAMILIAL THROMBOCYTOSIS	0.035714300000000004	1.776180512740663
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	1.776180512740663
FAMILIAL CERVICAL ARTERY DISSECTION	0.035714300000000004	1.776180512740663
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	1.776180512740663
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.035714300000000004	1.776180512740663
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.035714300000000004	1.776180512740663
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	1.776180512740663
FABRY DISEASE	0.035714300000000004	1.776180512740663
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	1.776180512740663
JUVENILE POLYPOSIS SYNDROME	0.035714300000000004	1.776180512740663
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.03542072	1.761579888482861
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.03542072	1.761579888482861
COG5-CDG	0.03523923	1.752553840058076
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03523923	1.752553840058076
ADNP SYNDROME	0.03523923	1.752553840058076
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.035028354	1.7420663366825455
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.035028354	1.7420663366825455
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.035028354	1.7420663366825455
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.035028354	1.7420663366825455
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035028354	1.7420663366825455
YUNIS-VARON SYNDROME	0.035028354	1.7420663366825455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.035028354	1.7420663366825455
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.035028354	1.7420663366825455
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	1.7420663366825455
JAWAD SYNDROME	0.035028354	1.7420663366825455
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	1.7420663366825455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.035028354	1.7420663366825455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.035028354	1.7420663366825455
HYDRANENCEPHALY	0.035028354	1.7420663366825455
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.034802394	1.7308286602151675
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.714934280798832
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.0344828	1.714934280798832
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	1.714934280798832
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.0344828	1.714934280798832
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0344828	1.714934280798832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.0344828	1.714934280798832
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0344828	1.714934280798832
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	1.714934280798832
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.714934280798832
9P13 MICRODELETION SYNDROME	0.0344828	1.714934280798832
DYSTONIA 7, TORSION	0.0344828	1.714934280798832
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.714934280798832
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	1.714934280798832
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	1.714934280798832
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0344828	1.714934280798832
SCHINZEL-GIEDION SYNDROME	0.0344828	1.714934280798832
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.0344828	1.714934280798832
SPINOCEREBELLAR ATAXIA TYPE 27	0.0344828	1.714934280798832
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0344828	1.714934280798832
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0344828	1.714934280798832
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0344828	1.714934280798832
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0344828	1.714934280798832
NORMAL PRESSURE HYDROCEPHALUS	0.0344828	1.714934280798832
RAMOS-ARROYO SYNDROME	0.0344828	1.714934280798832
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.0344828	1.714934280798832
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	1.714934280798832
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0344828	1.714934280798832
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0344828	1.714934280798832
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.0344828	1.714934280798832
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.0344828	1.714934280798832
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0344828	1.714934280798832
MODY	0.0344828	1.714934280798832
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0344828	1.714934280798832
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0344828	1.714934280798832
SPINAL MUSCULAR ATROPHY, TYPE II	0.0344828	1.714934280798832
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0344828	1.714934280798832
COWDEN SYNDROME 6; CWS6	0.0343552	1.7085883456012863
COWDEN SYNDROME 5; CWS5	0.0343552	1.7085883456012863
YOU-HOOVER-FONG SYNDROME; YHFS	0.033560084	1.669044814170786
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033560084	1.669044814170786
WOLF-HIRSCHHORN SYNDROME	0.033560084	1.669044814170786
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	1.6511208296179938
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.6511208296179938
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.6511208296179938
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.033151994000000004	1.6487492601365665
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.033091254	1.6457284756232518
ATYPICAL RETT SYNDROME	0.03301453	1.6419127582870723
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.03301453	1.6419127582870723
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.03301453	1.6419127582870723
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.03301453	1.6419127582870723
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.03301453	1.6419127582870723
ISOLATED CEREBELLAR AGENESIS	0.03301453	1.6419127582870723
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.033006754	1.641526034211084
MONOMELIC AMYOTROPHY	0.03284823	1.6336421546557882
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.6314252549115418
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.6314252549115418
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.6314252549115418
GRISCELLI SYNDROME TYPE 1	0.032803653999999995	1.6314252549115418
SARCOSINEMIA	0.032803653999999995	1.6314252549115418
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.032461199999999996	1.61439397832737
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.032334824	1.6081089163640077
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.6042931990278282
DIENCEPHALIC SYNDROME	0.0322581	1.6042931990278282
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.6042931990278282
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.6042931990278282
FLYNN-AIRD SYNDROME	0.0322581	1.6042931990278282
HUNTINGTON DISEASE	0.0322581	1.6042931990278282
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.6042931990278282
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.6042931990278282
LEIGH SYNDROME	0.0322581	1.6042931990278282
LESCH-NYHAN SYNDROME	0.0322581	1.6042931990278282
SANDHOFF DISEASE	0.0322581	1.6042931990278282
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.6042931990278282
MERRF	0.0322581	1.6042931990278282
PARKINSON DISEASE, LATE-ONSET; PD	0.03200783	1.591846512492642
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.03184915	1.5839548745839698
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.031520494	1.5676098144093258
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.031520493999999996	1.5676098144093253
SLC35A2-CDG	0.030713783999999997	1.5274896781772553
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030080234	1.4959813141928895
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.029957354	1.4898701189180115
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.029899454	1.4869905762225732
CHARGE SYNDROME	0.029873384	1.4856940360141093
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.029873384	1.4856940360141093
PENTASOMY X	0.029873384	1.4856940360141093
GALLOWAY-MOWAT SYNDROME	0.029873384	1.4856940360141093
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.029873384	1.4856940360141093
ALG1-CDG	0.029873384	1.4856940360141093
22Q11.2 MICRODUPLICATION SYNDROME	0.029873384	1.4856940360141093
FETAL ALCOHOL SYNDROME	0.029873384	1.4856940360141093
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029873384	1.4856940360141093
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.4627380630342977
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.4627380630342977
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.4627380630342977
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.4627380630342977
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.4627380630342977
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.4627380630342977
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.4627380630342977
SHORT SYNDROME	0.0294118	1.4627380630342977
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.4627380630342977
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.4627380630342977
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.4627380630342977
IMMUNE SUPPRESSION	0.0294118	1.4627380630342977
TRICHOHEPATOENTERIC SYNDROME 1	0.0294118	1.4627380630342977
RAGWEED SENSITIVITY	0.0294118	1.4627380630342977
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.4627380630342977
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.4627380630342977
MYASTHENIA GRAVIS; MG	0.0294118	1.4627380630342977
HYPOADRENOCORTICISM, FAMILIAL	0.02939397	1.4618513230298131
COFS SYNDROME	0.02932783	1.4585619801303955
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.02932783	1.4585619801303955
DISTAL MONOSOMY 7Q36	0.02932783	1.4585619801303955
SCHWARTZ-JAMPEL SYNDROME	0.02932783	1.4585619801303955
C SYNDROME	0.02932783	1.4585619801303955
NORRIE DISEASE	0.02932783	1.4585619801303955
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.029143024	1.4493710169633294
WAISMAN SYNDROME; WSMN	0.029116954	1.4480744767548654
TETRASOMY X	0.029116954	1.4480744767548654
MAN1B1-CDG	0.029116954	1.4480744767548654
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029116954	1.4480744767548654
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.028950053999999996	1.439774033302903
CITRULLINEMIA, CLASSIC	0.028950053999999996	1.439774033302903
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.4209424208711514
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0285714	1.4209424208711514
ACRODYSOSTOSIS	0.0285714	1.4209424208711514
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0285714	1.4209424208711514
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0285714	1.4209424208711514
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0285714	1.4209424208711514
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	1.4209424208711514
COG7-CDG	0.0285714	1.4209424208711514
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.4209424208711514
ALPHA-THALASSEMIA	0.0285714	1.4209424208711514
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.4209424208711514
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.4209424208711514
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.4209424208711514
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.4209424208711514
DOWN SYNDROME	0.0285714	1.4209424208711514
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.4209424208711514
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0285714	1.4209424208711514
ALG12-CDG	0.0285714	1.4209424208711514
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.4209424208711514
ATYPICAL JUVENILE PARKINSONISM	0.0285714	1.4209424208711514
PARKINSONISM WITH SPASTICITY, X-LINKED	0.0285714	1.4209424208711514
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.4209424208711514
CHEILITIS GLANDULARIS	0.0285714	1.4209424208711514
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0285714	1.4209424208711514
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.0285714	1.4209424208711514
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.0285714	1.4209424208711514
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	1.4209424208711514
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.027407519999999998	1.3630591367197442
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.026485324	1.3171955312696195
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.026302674	1.3081117925248569
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.026292354	1.3075985476091934
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.02593977	1.290063475385906
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.025668154000000002	1.276555187497061
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.025427604	1.2645919060568602
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0253265	1.2595636973404598
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.025234674	1.2549969117178121
LYSINURIC PROTEIN INTOLERANCE	0.0248069	1.2337224126332127
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.024671174	1.2269723467976164
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.024671174	1.2269723467976164
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.024540224	1.2204598059346177
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	1.2089240296586652
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.02412562	1.1998402909139025
POTOCKI-LUPSKI SYNDROME	0.024029283999999998	1.1950492093058243
FETAL HYDANTOIN SYNDROME	0.024029283999999998	1.1950492093058243
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024029283999999998	1.1950492093058243
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.02393269	1.1902452965748545
KAGAMI-OGATA SYNDROME	0.023272854	1.1574296500465802
SILVER-RUSSELL SYNDROME; SRS	0.023272854	1.1574296500465802
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.023010454000000003	1.1443797018033515
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.1302975941628663
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.1302975941628663
WATSON SYNDROME	0.0227273	1.1302975941628663
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.1302975941628663
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.1302975941628663
SIRENOMELIA	0.0227273	1.1302975941628663
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.1302975941628663
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.1302975941628663
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	1.1302975941628663
RHOMBENCEPHALOSYNAPSIS	0.0227273	1.1302975941628663
BETHLEM MYOPATHY 1	0.0227273	1.1302975941628663
MILLER-DIEKER SYNDROME	0.0227273	1.1302975941628663
ARTERIES, ANOMALIES OF	0.0227273	1.1302975941628663
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	1.1302975941628663
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.1302975941628663
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.1302975941628663
THUMB DEFORMITY	0.0227273	1.1302975941628663
COCAINE EMBRYOFETOPATHY	0.0227273	1.1302975941628663
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	1.1302975941628663
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	1.1302975941628663
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	1.1302975941628663
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.1302975941628663
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.1302975941628663
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.1302975941628663
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.1302975941628663
LARSEN SYNDROME	0.0227273	1.1302975941628663
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	1.1302975941628663
FATCO SYNDROME	0.0227273	1.1302975941628663
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	1.1267406875380352
SPINAL ARACHNOIDITIS	0.02265578	1.1267406875380352
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02265578	1.1267406875380352
NEPHROSIALIDOSIS	0.02265578	1.1267406875380352
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	1.1267406875380352
TRICHOTHIODYSTROPHY	0.022363843999999997	1.1122218243888915
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.02233395	1.1107351050566392
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.022274454	1.1077761884381971
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.022135283999999998	1.1008548420319084
LYSINURIC PROTEIN INTOLERANCE; LPI	0.02155522	1.0720064991288585
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02148216	1.0683730036309533
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02137257	1.0629227603840956
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.02137257	1.0629227603840956
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.02137257	1.0629227603840956
INFANTILE LIVER FAILURE SYNDROME 2	0.02137257	1.0629227603840956
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.02137257	1.0629227603840956
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.021286404	1.0586374637365112
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.021103794	1.049555714313127
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.021103794	1.049555714313127
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021093473999999997	1.0490424693974634
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.0458499069831122
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.0458499069831122
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.0458499069831122
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.0458499069831122
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.0458499069831122
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0208333	1.0361032268889505
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0208333	1.0361032268889505
PRIMARY DYSTONIA, DYT13 TYPE	0.0208333	1.0361032268889505
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0208333	1.0361032268889505
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0208333	1.0361032268889505
LEBER HEREDITARY OPTIC NEUROPATHY	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0208333	1.0361032268889505
MANGANESE POISONING	0.0208333	1.0361032268889505
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.0208333	1.0361032268889505
DYSTONIA 16	0.0208333	1.0361032268889505
PRIMARY PROGRESSIVE FREEZING GAIT	0.0208333	1.0361032268889505
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA 15	0.0208333	1.0361032268889505
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0208333	1.0361032268889505
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0208333	1.0361032268889505
GILLESPIE SYNDROME; GLSP	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA TYPE 1	0.0208333	1.0361032268889505
DYSTONIA 27; DYT27	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA 20	0.0208333	1.0361032268889505
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0205177	1.020407481212262
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.020365269999999998	1.012826674768987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.020365269999999998	1.012826674768987
COG8-CDG	0.020365269999999998	1.012826674768987
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020169884	1.0031095360972968
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.019779203999999998	0.9836798341930868
PROTOPORPHYRIA, ERYTHROPOIETIC	0.01953496	0.9715328389235778
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.019443074	0.9669630693188624
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019443074	0.9669630693188624
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.9654899768380527
BAND HETEROTOPIA; BH	0.019413454	0.9654899768380527
VESICOURETERAL REFLUX 1	0.0188679	0.9383579209543389
TOE, MISSHAPEN	0.0188679	0.9383579209543389
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.9383579209543389
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.9383579209543389
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.9383579209543389
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.9383579209543389
KNUCKLE PADS	0.0188679	0.9383579209543389
MONOPHALANGY OF GREAT TOE	0.0188679	0.9383579209543389
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.9383579209543389
CARPAL DISPLACEMENT	0.0188679	0.9383579209543389
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.9383579209543389
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.9383579209543389
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.9383579209543389
HHHH SYNDROME	0.0188679	0.9383579209543389
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.9383579209543389
RAYNAUD DISEASE	0.0188679	0.9383579209543389
PUBIC BONE DYSPLASIA	0.0188679	0.9383579209543389
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.9383579209543389
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.9383579209543389
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.9383579209543389
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.9383579209543389
VAN DEN BOSCH SYNDROME	0.0188679	0.9383579209543389
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.9383579209543389
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.9383579209543389
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.9383579209543389
TRACHEOBRONCHOMEGALY	0.0188679	0.9383579209543389
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.9383579209543389
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.9383579209543389
THROMBOCYTOPENIA 3	0.0188679	0.9383579209543389
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.9383579209543389
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.9383579209543389
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.9383579209543389
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.9383579209543389
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.9383579209543389
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.9383579209543389
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.9383579209543389
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.9383579209543389
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.9383579209543389
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.9383579209543389
LETTERER-SIWE DISEASE	0.0188679	0.9383579209543389
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.018840124	0.9369765361890801
FUMARASE DEFICIENCY; FMRD	0.018760934	0.9330381771899136
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.018760934	0.9330381771899136
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.018215380000000003	0.9059061213061999
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.018069654	0.8986587251259682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.01802245	0.8963111269671519
WILLIAMS SYNDROME	0.017891459999999998	0.8897965967827748
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.017873554	0.8889060770676709
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.017811574	0.8858236235916217
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.017680584	0.8793090934072446
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.017680584	0.8793090934072446
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.017628924	0.8767398848468589
PEARSON SYNDROME	0.01745895	0.8682865620469558
COLCHICINE POISONING	0.01745895	0.8682865620469558
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.017328	0.8617740211839571
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.017328	0.8617740211839571
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.017328	0.8617740211839571
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01726602	0.8586915677079079
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01726602	0.8586915677079079
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	0.8586915677079079
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	0.8586915677079079
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.857467140399416
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.857467140399416
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.857467140399416
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.857467140399416
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.857467140399416
MOSAIC TRISOMY 15	0.0172414	0.857467140399416
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.857467140399416
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.857467140399416
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.857467140399416
ALCOHOL DEPENDENCE	0.0172414	0.857467140399416
MOTION SICKNESS	0.0172414	0.857467140399416
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.857467140399416
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.857467140399416
TRANSSEXUALITY	0.0172414	0.857467140399416
DIASTEMATOMYELIA	0.0172414	0.857467140399416
PALMOMENTAL REFLEX	0.0172414	0.857467140399416
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.857467140399416
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.857467140399416
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.857467140399416
CERVICAL RIB	0.0172414	0.857467140399416
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.857467140399416
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.857467140399416
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.857467140399416
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.857467140399416
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.857467140399416
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.857467140399416
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.857467140399416
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.857467140399416
CARDIAC ARRHYTHMIA	0.0172414	0.857467140399416
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.857467140399416
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.857467140399416
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.857467140399416
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.857467140399416
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.857467140399416
JUMPING FRENCHMAN OF MAINE	0.0172414	0.857467140399416
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.857467140399416
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.857467140399416
269800 SENILE PLAQUE FORMATION	0.0172414	0.857467140399416
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.857467140399416
SICKLE CELL ANEMIA	0.0172414	0.857467140399416
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.857467140399416
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.857467140399416
ERYTHERMALGIA, PRIMARY	0.0172414	0.857467140399416
MYOPATHY, CONGENITAL	0.0172414	0.857467140399416
GLYCOGEN STORAGE DISEASE IXC	0.01714325	0.8525858430668208
SNEDDON SYNDROME	0.01713503	0.8521770375235308
RIBOFLAVIN DEFICIENCY	0.01708337	0.8496078289631451
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.01708337	0.8496078289631451
GLUTARIC ACIDEMIA I; GA1	0.01708337	0.8496078289631451
GLYCOGEN STORAGE DISEASE IXA	0.016767670000000002	0.8339071099830104
GLYCOGEN STORAGE DISEASE VI	0.016767670000000002	0.8339071099830104
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.016767670000000002	0.8339071099830104
HYPERMANGANESEMIA WITH DYSTONIA 2	0.016030184000000003	0.7972296933286435
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.015961334	0.7938055739058296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.015484630000000003	0.7700976374449297
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.01546233	0.7689885907763929
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.01541578	0.7666735180221158
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.01541578	0.7666735180221158
ARGININOSUCCINIC ACIDURIA	0.015251454	0.7585010874008626
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.015251454	0.7585010874008626
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.015251454	0.7585010874008626
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.015251454	0.7585010874008626
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.015251454	0.7585010874008626
ARGININEMIA	0.015251454	0.7585010874008626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.015193554	0.7556215447054246
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.015193554	0.7556215447054246
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.015193554	0.7556215447054246
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.015010904	0.7465378059606618
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.015010903999999999	0.7465378059606618
ISOLATED COMPLEX I DEFICIENCY	0.015010903999999999	0.7465378059606618
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.015000583999999999	0.7460245610449981
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.015000583999999999	0.7460245610449981
CEDNIK SYNDROME	0.015000583999999999	0.7460245610449981
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.015000583999999999	0.7460245610449981
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.0147059	0.7313690315171488
GLUTAMINE DEFICIENCY, CONGENITAL	0.0147059	0.7313690315171488
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0147059	0.7313690315171488
PATENT DUCTUS VENOSUS	0.0147059	0.7313690315171488
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.0147059	0.7313690315171488
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0147059	0.7313690315171488
CITRULLINEMIA TYPE I	0.0147059	0.7313690315171488
ARGININOSUCCINIC ACIDURIA	0.0147059	0.7313690315171488
CONGENITAL ENTEROVIRUS INFECTION	0.0147059	0.7313690315171488
SPLENOPORTAL VASCULAR ANOMALIES	0.0147059	0.7313690315171488
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0147059	0.7313690315171488
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.014648	0.7284894888217107
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.014648	0.7284894888217107
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.014648	0.7284894888217107
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.01446535	0.719405750076948
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.014455029999999999	0.7188925051612843
UNILATERAL POLYMICROGYRIA	0.014455029999999999	0.7188925051612843
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014437123999999999	0.7180019854461805
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.014437123999999999	0.7180019854461805
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.014437123999999999	0.7180019854461805
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.014437123999999999	0.7180019854461805
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.014437123999999999	0.7180019854461805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.014437123999999999	0.7180019854461805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.014437123999999999	0.7180019854461805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014437123999999999	0.7180019854461805
LEIGH SYNDROME; LS	0.014437123999999999	0.7180019854461805
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.014254474	0.7089182467014177
2P21 MICRODELETION SYNDROME	0.014254474	0.7089182467014177
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.014244153999999998	0.708405001785754
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014244153999999998	0.708405001785754
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.014244153999999998	0.708405001785754
ABETAL34V AMYLOIDOSIS	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.014244153999999998	0.708405001785754
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014244153999999998	0.708405001785754
WRINKLY SKIN SYNDROME	0.014244153999999998	0.708405001785754
MEIER-GORLIN SYNDROME 7	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.014244153999999998	0.708405001785754
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014244153999999998	0.708405001785754
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.014244153999999998	0.708405001785754
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.014244153999999998	0.708405001785754
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014244153999999998	0.708405001785754
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.014244153999999998	0.708405001785754
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.014244153999999998	0.708405001785754
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014244153999999998	0.708405001785754
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014244153999999998	0.708405001785754
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014244153999999998	0.708405001785754
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014244153999999998	0.708405001785754
DE BARSY SYNDROME	0.014244153999999998	0.708405001785754
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014244153999999998	0.708405001785754
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.014244153999999998	0.708405001785754
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.014244153999999998	0.708405001785754
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014244153999999998	0.708405001785754
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.014244153999999998	0.708405001785754
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.014244153999999998	0.708405001785754
PEHO-LIKE SYNDROME; PEHOL	0.014244153999999998	0.708405001785754
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.014244153999999998	0.708405001785754
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.014244153999999998	0.708405001785754
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014244153999999998	0.708405001785754
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014244153999999998	0.708405001785754
PEHO SYNDROME; PEHO	0.014244153999999998	0.708405001785754
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014244153999999998	0.708405001785754
CLASSIC PHENYLKETONURIA	0.014172374000000001	0.7048351645719624
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.6908699295624667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.013891569999999999	0.6908699295624667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.013891569999999999	0.6908699295624667
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	0.6908699295624667
LIVER FAILURE, INFANTILE, TRANSIENT	0.013891569999999999	0.6908699295624667
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	0.6908699295624667
NEUROLEPTIC MALIGNANT SYNDROME	0.013853130000000002	0.688958191717689
CUTIS LAXA	0.013767393999999999	0.6846942802749241
MAPLE SYRUP URINE DISEASE; MSUD	0.01370892	0.681786190817704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.681786190817704
GLYCOGEN STORAGE DISEASE IA	0.01370892	0.681786190817704
GLYCOGEN STORAGE DISEASE IB	0.01370892	0.681786190817704
STROKE, ISCHEMIC	0.013698599999999998	0.6812729459020402
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.6812729459020402
EISENMENGER SYNDROME	0.013698599999999998	0.6812729459020402
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.013698599999999998	0.6812729459020402
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.6812729459020402
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.013698599999999998	0.6812729459020402
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.013698599999999998	0.6812729459020402
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.013698599999999998	0.6812729459020402
WALDENSTRÖM MACROGLOBULINEMIA	0.013698599999999998	0.6812729459020402
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.6812729459020402
AMYLOIDOSIS VI	0.013698599999999998	0.6812729459020402
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	0.6812729459020402
SICKLE CELL ANEMIA	0.013698599999999998	0.6812729459020402
WILLIAMS-BEUREN SYNDROME; WBS	0.013698599999999998	0.6812729459020402
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.6812729459020402
AORTA COARCTATION	0.013698599999999998	0.6812729459020402
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.6812729459020402
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	0.6812729459020402
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.013698599999999998	0.6812729459020402
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.013698599999999998	0.6812729459020402
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013698599999999998	0.6812729459020402
RETT SYNDROME, CONGENITAL VARIANT	0.013698599999999998	0.6812729459020402
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.013698599999999998	0.6812729459020402
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.013698599999999998	0.6812729459020402
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.6812729459020402
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.013698599999999998	0.6812729459020402
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.013698599999999998	0.6812729459020402
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.6812729459020402
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.013698599999999998	0.6812729459020402
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.6812729459020402
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.6812729459020402
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.6812729459020402
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	0.6812729459020402
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.6812729459020402
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.6812729459020402
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.6812729459020402
SECONDARY POLYCYTHEMIA	0.013698599999999998	0.6812729459020402
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.013698599999999998	0.6812729459020402
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.013698599999999998	0.6812729459020402
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.6812729459020402
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.013698599999999998	0.6812729459020402
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.013698599999999998	0.6812729459020402
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	0.6812729459020402
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.6812729459020402
ABETA AMYLOIDOSIS, DUTCH TYPE	0.013698599999999998	0.6812729459020402
COG1-CDG	0.013698599999999998	0.6812729459020402
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.013698599999999998	0.6812729459020402
ABETA AMYLOIDOSIS, IOWA TYPE	0.013698599999999998	0.6812729459020402
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.6812729459020402
PRADER-WILLI SYNDROME	0.013698599999999998	0.6812729459020402
ACYS AMYLOIDOSIS	0.013698599999999998	0.6812729459020402
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.013698599999999998	0.6812729459020402
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.6812729459020402
STURGE-WEBER SYNDROME	0.013698599999999998	0.6812729459020402
POLYCYTHEMIA VERA	0.013698599999999998	0.6812729459020402
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.013698599999999998	0.6812729459020402
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.6812729459020402
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.6812729459020402
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.013698599999999998	0.6812729459020402
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01353743	0.6732574727375541
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.01353743	0.6732574727375541
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.013350184000000003	0.6639451609663971
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.013350184000000003	0.6639451609663971
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013350184000000003	0.6639451609663971
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.012929884	0.6430423665813775
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.012929884	0.6430423665813775
BRAIN-LUNG-THYROID SYNDROME	0.012929884	0.6430423665813775
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.012929884	0.6430423665813775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.012593754000000002	0.626325601707153
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012593754000000002	0.626325601707153
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.012593754000000002	0.626325601707153
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.012593754000000002	0.626325601707153
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.012593754000000002	0.626325601707153
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.012593754000000002	0.626325601707153
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012593754000000002	0.626325601707153
8Q24.3 MICRODELETION SYNDROME	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.012593754000000002	0.626325601707153
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.012593754000000002	0.626325601707153
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.012593754000000002	0.626325601707153
LISSENCEPHALY 1; LIS1	0.012593754000000002	0.626325601707153
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.012593754000000002	0.626325601707153
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.012593754000000002	0.626325601707153
COG2-CDG	0.012593754000000002	0.626325601707153
RECOMBINANT CHROMOSOME 8 SYNDROME	0.012593754000000002	0.626325601707153
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, X-LINKED 98; MRX98	0.012593754000000002	0.626325601707153
WEBB-DATTANI SYNDROME; WEDAS	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012593754000000002	0.626325601707153
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.012593754000000002	0.626325601707153
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.012593754000000002	0.626325601707153
VERVERI-BRADY SYNDROME; VERBRAS	0.01238433	0.6159103106976637
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.01238433	0.6159103106976637
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.012173454	0.6054228073221335
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.012173454	0.6054228073221335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.012173454	0.6054228073221335
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.012173454	0.6054228073221335
SPINOCEREBELLAR ATAXIA 5; SCA5	0.012173454	0.6054228073221335
SPINOCEREBELLAR ATAXIA TYPE 29	0.012173454	0.6054228073221335
CEREBELLAR ATAXIA, CAYMAN TYPE	0.012173454	0.6054228073221335
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.012173454	0.6054228073221335
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012173454	0.6054228073221335
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.012173454	0.6054228073221335
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.012173454	0.6054228073221335
PEROXISOME BIOGENESIS DISORDER 6B	0.012173454	0.6054228073221335
MEDULLOBLASTOMA	0.012173454	0.6054228073221335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.012173454	0.6054228073221335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.012048200000000002	0.5991935458234392
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.012048200000000002	0.5991935458234392
BARAITSER-WINTER SYNDROME 2; BRWS2	0.012048200000000002	0.5991935458234392
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.5991935458234392
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012048200000000002	0.5991935458234392
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.5991935458234392
RETT SYNDROME; RTT	0.012048200000000002	0.5991935458234392
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.012048200000000002	0.5991935458234392
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.012048200000000002	0.5991935458234392
MENTAL RETARDATION, X-LINKED 1	0.012048200000000002	0.5991935458234392
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.012048200000000002	0.5991935458234392
PALLISTER-KILLIAN SYNDROME	0.012048200000000002	0.5991935458234392
WARBURG MICRO SYNDROME 2; WARBM2	0.012048200000000002	0.5991935458234392
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012048200000000002	0.5991935458234392
WARBURG MICRO SYNDROME 3; WARBM3	0.012048200000000002	0.5991935458234392
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.5991935458234392
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.011718684000000002	0.5828057152391564
SPINOCEREBELLAR ATAXIA TYPE 10	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 6	0.0116279	0.5782907514384196
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0116279	0.5782907514384196
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0116279	0.5782907514384196
UNVERRICHT-LUNDBORG DISEASE	0.0116279	0.5782907514384196
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.0116279	0.5782907514384196
EPISODIC ATAXIA, TYPE 8	0.0116279	0.5782907514384196
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0116279	0.5782907514384196
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0116279	0.5782907514384196
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 35	0.0116279	0.5782907514384196
DEMENTIA, FAMILIAL DANISH	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0116279	0.5782907514384196
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.5782907514384196
BOUCHER-NEUHAUSER SYNDROME	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.0116279	0.5782907514384196
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA 40; SCA40	0.0116279	0.5782907514384196
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0116279	0.5782907514384196
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0116279	0.5782907514384196
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0116279	0.5782907514384196
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0116279	0.5782907514384196
MYOCLONUS AND ATAXIA	0.0116279	0.5782907514384196
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0116279	0.5782907514384196
FRIEDREICH ATAXIA	0.0116279	0.5782907514384196
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.0116279	0.5782907514384196
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0116279	0.5782907514384196
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0116279	0.5782907514384196
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0116279	0.5782907514384196
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0116279	0.5782907514384196
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 40	0.0116279	0.5782907514384196
SALT-AND-PEPPER SYNDROME	0.011587734	0.5762931743761577
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.011587733999999999	0.5762931743761577
GALACTOSEMIA	0.011405084	0.5672094356313949
SMITH-MAGENIS SYNDROME	0.011402984000000001	0.5671049962590216
AMISH LETHAL MICROCEPHALY	0.011173130000000002	0.5556736593554426
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.011024234	0.5482686094559615
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.010962254000000001	0.5451861559799123
HYDROXYKYNURENINURIA	0.010962254000000001	0.5451861559799123
ISOVALERIC ACIDEMIA	0.010962254000000001	0.5451861559799123
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010962254000000001	0.5451861559799123
MICROVILLUS INCLUSION DISEASE	0.010962254000000001	0.5451861559799123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010962254000000001	0.5451861559799123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010962254000000001	0.5451861559799123
ROIFMAN SYNDROME; RFMN	0.010735944	0.5339310729504719
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.010735944	0.5339310729504719
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.010735944	0.5339310729504719
KOOLEN-DE VRIES SYNDROME; KDVS	0.010735944	0.5339310729504719
2Q37 MICRODELETION SYNDROME	0.010735944	0.5339310729504719
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.010735944	0.5339310729504719
SAY-BARBER-MILLER SYNDROME	0.010735944	0.5339310729504719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.010735944	0.5339310729504719
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010735944	0.5339310729504719
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.010735944	0.5339310729504719
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.010735944	0.5339310729504719
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010646554	0.5294854369997776
ALSTROM SYNDROME; ALMS	0.010646554	0.5294854369997776
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.010646554	0.5294854369997776
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.010646554	0.5294854369997776
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.010646554	0.5294854369997776
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.010646554	0.5294854369997776
ALSTRÖM SYNDROME	0.010646554	0.5294854369997776
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	0.5180541000961986
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	0.5180541000961986
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.5180541000961986
HAWKINSINURIA	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.010416700000000001	0.5180541000961986
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.5180541000961986
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.5180541000961986
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.5180541000961986
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.5180541000961986
PRIMARY HYPEROXALURIA	0.010416700000000001	0.5180541000961986
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.010416700000000001	0.5180541000961986
HAWKINSINURIA	0.010416700000000001	0.5180541000961986
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.01028575	0.5115415592331999
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.01019039	0.5067990170667582
PHENYLKETONURIA	0.01019039	0.5067990170667582
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01019039	0.5067990170667582
ROIFMAN SYNDROME	0.01019039	0.5067990170667582
DUBOWITZ SYNDROME	0.01019039	0.5067990170667582
DUBOWITZ SYNDROME	0.01019039	0.5067990170667582
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.01019039	0.5067990170667582
IMMUNODEFICIENCY 55; IMD55	0.01019039	0.5067990170667582
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01019039	0.5067990170667582
DISTAL TRISOMY 5Q	0.01019039	0.5067990170667582
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01019039	0.5067990170667582
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.01019039	0.5067990170667582
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.01019039	0.5067990170667582
XQ12-Q13.3 DUPLICATION SYNDROME	0.01019039	0.5067990170667582
CLASSIC GALACTOSEMIA	0.0101031	0.5024578204884371
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.5023533811160638
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.5023533811160638
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.5023533811160638
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.010101	0.5023533811160638
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.010101	0.5023533811160638
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.010101	0.5023533811160638
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.5023533811160638
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.5023533811160638
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.5023533811160638
NIEMANN-PICK DISEASE TYPE B	0.010101	0.5023533811160638
DYSBETALIPOPROTEINEMIA	0.010101	0.5023533811160638
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.5023533811160638
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.5023533811160638
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.010101	0.5023533811160638
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.5023533811160638
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.010101	0.5023533811160638
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.010101	0.5023533811160638
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.5023533811160638
TEMPLE SYNDROME	0.010101	0.5023533811160638
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.5023533811160638
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.5023533811160638
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.5023533811160638
FISH-EYE DISEASE	0.010101	0.5023533811160638
LCAT DEFICIENCY	0.010101	0.5023533811160638
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.5023533811160638
RECURRENT ACUTE PANCREATITIS	0.010101	0.5023533811160638
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.010101	0.5023533811160638
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.5023533811160638
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.5023533811160638
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
TANGIER DISEASE	0.010101	0.5023533811160638
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.5023533811160638
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.5023533811160638
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.5023533811160638
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.5023533811160638
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.010101	0.5023533811160638
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
ATHEROSCLEROSIS SUSCEPTIBILITY	0.010101	0.5023533811160638
MANDIBULOACRAL DYSPLASIA	0.010101	0.5023533811160638
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.5023533811160638
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.5023533811160638
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.5023533811160638
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.5023533811160638
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.010101	0.5023533811160638
NIEMANN-PICK DISEASE, TYPE B	0.010101	0.5023533811160638
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.5023533811160638
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.5023533811160638
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.5023533811160638
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.5023533811160638
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.5023533811160638
H SYNDROME	0.010101	0.5023533811160638
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.010101	0.5023533811160638
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.009979514	0.4963115136912279
SULFOCYSTEINURIA	0.009979514	0.4963115136912279
CHROMOSOME 2Q37 DELETION SYNDROME	0.009979514	0.4963115136912279
SHWACHMAN-DIAMOND SYNDROME	0.009979514	0.4963115136912279
NETHERTON SYNDROME	0.009979514	0.4963115136912279
PELGER-HUET ANOMALY; PHA	0.009979514	0.4963115136912279
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009979514	0.4963115136912279
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.009979514	0.4963115136912279
JACOBSEN SYNDROME	0.009979514	0.4963115136912279
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.009979514	0.4963115136912279
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.009979514	0.4963115136912279
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00943396	0.4691794578075141
CLASSICAL EHLERS-DANLOS SYNDROME	0.00943396	0.4691794578075141
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.4691794578075141
BULLOUS PEMPHIGOID	0.00943396	0.4691794578075141
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00943396	0.4691794578075141
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00943396	0.4691794578075141
WISKOTT-ALDRICH SYNDROME	0.00943396	0.4691794578075141
PITYRIASIS RUBRA PILARIS	0.00943396	0.4691794578075141
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00943396	0.4691794578075141
8Q21.11 MICRODELETION SYNDROME	0.00943396	0.4691794578075141
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.4691794578075141
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00943396	0.4691794578075141
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00943396	0.4691794578075141
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00943396	0.4691794578075141
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00943396	0.4691794578075141
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00943396	0.4691794578075141
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00943396	0.4691794578075141
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.00943396	0.4691794578075141
DERMATITIS HERPETIFORMIS	0.00943396	0.4691794578075141
IMMUNODEFICIENCY 50; IMD50	0.00943396	0.4691794578075141
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00943396	0.4691794578075141
CHRONIC GRANULOMATOUS DISEASE	0.00943396	0.4691794578075141
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00943396	0.4691794578075141
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.4691794578075141
CRANIO-OSTEOARTHROPATHY	0.00943396	0.4691794578075141
THROMBOCYTOPENIA 1	0.00943396	0.4691794578075141
BAZEX SYNDROME; BZX	0.00943396	0.4691794578075141
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00943396	0.4691794578075141
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00943396	0.4691794578075141
MYCOSIS FUNGOIDES	0.00943396	0.4691794578075141
BLAU SYNDROME	0.00943396	0.4691794578075141
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00943396	0.4691794578075141
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00943396	0.4691794578075141
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00943396	0.4691794578075141
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.4691794578075141
CASPASE 8 DEFICIENCY	0.00943396	0.4691794578075141
ECTODERMAL DYSPLASIA SYNDROME	0.00943396	0.4691794578075141
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.00943396	0.4691794578075141
ELASTODERMA	0.00943396	0.4691794578075141
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00943396	0.4691794578075141
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.4691794578075141
COFFIN-SIRIS SYNDROME 8; CSS8	0.00943396	0.4691794578075141
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.4691794578075141
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00943396	0.4691794578075141
CLASSIC MYCOSIS FUNGOIDES	0.00943396	0.4691794578075141
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00943396	0.4691794578075141
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.008344234	0.4149840770937152
INFANTILE LIVER FAILURE SYNDROME 1	0.008344234	0.4149840770937152
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.008344233999999999	0.4149840770937151
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.008344233999999999	0.4149840770937151
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.008151304	0.4053890827546673
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008151304	0.4053890827546673
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.008151304	0.4053890827546673
HOLOPROSENCEPHALY 1; HPE1	0.007968654	0.3963053440099045
MEHMO SYNDROME; MEHMO	0.007968654	0.3963053440099045
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.007968654	0.3963053440099045
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.007968654	0.3963053440099045
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.007968654	0.3963053440099045
HOLOPROSENCEPHALY	0.007968654	0.3963053440099045
3-HYDROXYISOBUTYRIC ACIDURIA	0.00779868	0.38785202121000134
PSEUDO-TORCH SYNDROME 2	0.00779868	0.38785202121000134
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00779868	0.38785202121000134
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00779868	0.38785202121000134
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00779868	0.38785202121000134
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00760575	0.37825702687095347
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00760575	0.37825702687095347
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.007587804	0.3773645178344711
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.007587804	0.3773645178344711
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.007587804	0.3773645178344711
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.007587804	0.3773645178344711
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.007587804	0.3773645178344711
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.007587804	0.3773645178344711
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.007587804	0.3773645178344711
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007587804	0.3773645178344711
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.007587804	0.3773645178344711
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007587804	0.3773645178344711
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.007587804	0.3773645178344711
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.007587804	0.3773645178344711
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007587804	0.3773645178344711
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.007587804	0.3773645178344711
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0074231	0.36917328812619066
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0074231	0.36917328812619066
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.0074231	0.36917328812619066
MENKES DISEASE	0.0074231	0.36917328812619066
LEPRECHAUNISM	0.0074231	0.36917328812619066
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007394874	0.36776952349542325
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007394874	0.36776952349542325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.007394874	0.36776952349542325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.007394874	0.36776952349542325
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007394874	0.36776952349542325
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.007394874	0.36776952349542325
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007394874	0.36776952349542325
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.007394874	0.36776952349542325
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007394874	0.36776952349542325
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007394874	0.36776952349542325
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.007394874	0.36776952349542325
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.007394874	0.36776952349542325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007394874	0.36776952349542325
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007394874	0.36776952349542325
PERRY SYNDROME	0.007224309999999999	0.3592868582051866
GLUTATHIONURIA	0.007224309999999999	0.3592868582051866
MYOPATHY, SPHEROID BODY	0.007224309999999999	0.3592868582051866
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.007224309999999999	0.3592868582051866
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.007224309999999999	0.3592868582051866
TIMOTHY SYNDROME; TS	0.007212224000000001	0.3586857847506605
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.007212224000000001	0.3586857847506605
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.007212224000000001	0.3586857847506605
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007212224000000001	0.3586857847506605
COSTELLO SYNDROME; CSTLO	0.007212224000000001	0.3586857847506605
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.007212224000000001	0.3586857847506605
SHASHI-PENA SYNDROME; SHAPNS	0.007212224000000001	0.3586857847506605
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007212224000000001	0.3586857847506605
PITUITARY STALK INTERRUPTION SYNDROME	0.007212224000000001	0.3586857847506605
MIRAGE SYNDROME; MIRAGE	0.007212224000000001	0.3586857847506605
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007212224000000001	0.3586857847506605
GRACILE SYNDROME	0.00704225	0.35023246195075725
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.35023246195075725
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.35023246195075725
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.35023246195075725
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00704225	0.35023246195075725
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.35023246195075725
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.35023246195075725
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.35023246195075725
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.35023246195075725
ETHYLMALONIC ENCEPHALOPATHY	0.00704225	0.35023246195075725
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00704225	0.35023246195075725
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.35023246195075725
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.35023246195075725
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.35023246195075725
SUCCINIC ACIDEMIA	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00704225	0.35023246195075725
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00684932	0.34063746761170943
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.34063746761170943
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.34063746761170943
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.34063746761170943
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.34063746761170943
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.34063746761170943
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.34063746761170943
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.34063746761170943
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.34063746761170943
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.34063746761170943
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00684932	0.34063746761170943
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.34063746761170943
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00684932	0.34063746761170943
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.34063746761170943
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00684932	0.34063746761170943
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.34063746761170943
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.34063746761170943
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.34063746761170943
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.34063746761170943
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.34063746761170943
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.34063746761170943
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.34063746761170943
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.34063746761170943
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.34063746761170943
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	0.3315537288669467
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.3315537288669467
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	0.3315537288669467
LARON SYNDROME	0.00666667	0.3315537288669467
HEPATOCELLULAR CARCINOMA	0.00666667	0.3315537288669467
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.3315537288669467
OCULODENTODIGITAL DYSPLASIA	0.00666667	0.3315537288669467
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.3315537288669467
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00666667	0.3315537288669467
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	0.3315537288669467
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.3315537288669467
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	0.3315537288669467
ENDOCARDIAL FIBROELASTOSIS	0.00666667	0.3315537288669467
NEONATAL HEMOCHROMATOSIS	0.00666667	0.3315537288669467
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.3315537288669467
PITUITARY APOPLEXY	0.00666667	0.3315537288669467
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.3315537288669467
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00666667	0.3315537288669467
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00666667	0.3315537288669467
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.3315537288669467
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.3315537288669467
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.3315537288669467
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	0.3315537288669467
SMITH-KINGSMORE SYNDROME; SKS	0.00666667	0.3315537288669467
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	0.3315537288669467
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.3315537288669467
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00666667	0.3315537288669467
CADASIL	0.00666667	0.3315537288669467
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.3315537288669467
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00666667	0.3315537288669467
SHEEHAN SYNDROME	0.00666667	0.3315537288669467
MPI-CDG	0.00666667	0.3315537288669467
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.3315537288669467
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.3315537288669467
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.3315537288669467
TENORIO SYNDROME; TNORS	0.00666667	0.3315537288669467
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	0.3315537288669467
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.3315537288669467
VISCERAL STEATOSIS, CONGENITAL	0.00666667	0.3315537288669467
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.3315537288669467
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.3315537288669467
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	0.3315537288669467
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.3315537288669467
PANHYPOPITUITARISM	0.00666667	0.3315537288669467
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00666667	0.3315537288669467
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00666667	0.3315537288669467
EMANUEL SYNDROME	0.0050898639999999995	0.25313438172665403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.0050898639999999995	0.25313438172665403
CHROMOSOME 10Q26 DELETION SYNDROME	0.0050898639999999995	0.25313438172665403
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0050898639999999995	0.25313438172665403
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0050898639999999995	0.25313438172665403
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0050898639999999995	0.25313438172665403
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0050898639999999995	0.25313438172665403
AICARDI-GOUTIERES SYNDROME 6	0.004738414	0.23565570676444825
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.004738414	0.23565570676444825
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004738414	0.23565570676444825
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.004738414	0.23565570676444825
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.004738414	0.23565570676444825
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.004738414	0.23565570676444825
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004738414	0.23565570676444825
JABERI-ELAHI SYNDROME; JABELS	0.004738414	0.23565570676444825
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.004738414	0.23565570676444825
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004738414	0.23565570676444825
AICARDI-GOUTIÈRES SYNDROME	0.004738414	0.23565570676444825
12Q14 MICRODELETION SYNDROME	0.004738414	0.23565570676444825
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.004738414	0.23565570676444825
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004738414	0.23565570676444825
PEDIATRIC-ONSET GRAVES DISEASE	0.004738414	0.23565570676444825
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.004738414	0.23565570676444825
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.004738414	0.23565570676444825
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004738414	0.23565570676444825
XYLOSIDASE DEFICIENCY	0.00454431	0.22600232584294022
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.22600232584294022
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00454431	0.22600232584294022
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00454431	0.22600232584294022
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00454431	0.22600232584294022
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00454431	0.22600232584294022
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.22600232584294022
ASPARTYLGLUCOSAMINURIA; AGU	0.00454431	0.22600232584294022
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.22600232584294022
46,XX GONADAL DYSGENESIS	0.00454431	0.22600232584294022
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004333434	0.21551482246740997
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.21551482246740997
LARSEN-LIKE SYNDROME	0.004333434	0.21551482246740997
SALLA DISEASE	0.004333434	0.21551482246740997
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.21551482246740997
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004333434	0.21551482246740997
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004333434	0.21551482246740997
REVESZ SYNDROME	0.004333434	0.21551482246740997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004333434	0.21551482246740997
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004333434	0.21551482246740997
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.21551482246740997
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.21551482246740997
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00419286	0.20852365088073443
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00419286	0.20852365088073443
CHROMOSOME 18Q DELETION SYNDROME	0.00419286	0.20852365088073443
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00419286	0.20852365088073443
TYROSINEMIA TYPE 2	0.00419286	0.20852365088073443
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00419286	0.20852365088073443
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00419286	0.20852365088073443
COCKAYNE SYNDROME	0.00419286	0.20852365088073443
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00419286	0.20852365088073443
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00419286	0.20852365088073443
COCKAYNE SYNDROME A; CSA	0.00419286	0.20852365088073443
MENTAL RETARDATION, X-LINKED 104; MRX104	0.003981984	0.19803614750520418
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.003981984	0.19803614750520418
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003981984	0.19803614750520418
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003981984	0.19803614750520418
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003981984	0.19803614750520418
JOUBERT SYNDROME WITH RENAL DEFECT	0.003981984	0.19803614750520418
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.003981984	0.19803614750520418
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003981984	0.19803614750520418
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003981984	0.19803614750520418
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.003981984	0.19803614750520418
GABRIELE-DE VRIES SYNDROME; GADEVS	0.003981984	0.19803614750520418
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.003981984	0.19803614750520418
JOUBERT SYNDROME	0.003981984	0.19803614750520418
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003981984	0.19803614750520418
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003981984	0.19803614750520418
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.003981984	0.19803614750520418
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003981984	0.19803614750520418
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.003981984	0.19803614750520418
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.003981984	0.19803614750520418
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.003981984	0.19803614750520418
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003981984	0.19803614750520418
TRISOMY X	0.003981984	0.19803614750520418
48,XXXY SYNDROME	0.003981984	0.19803614750520418
48,XXYY SYNDROME	0.003981984	0.19803614750520418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.003981984	0.19803614750520418
OROFACIODIGITAL SYNDROME TYPE 6	0.003981984	0.19803614750520418
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.003981984	0.19803614750520418
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003981984	0.19803614750520418
SIALIDOSIS TYPE 2	0.003981984	0.19803614750520418
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.003981984	0.19803614750520418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.003981984	0.19803614750520418
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.003981984	0.19803614750520418
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.003981984	0.19803614750520418
NIEMANN-PICK DISEASE TYPE C	0.003981984	0.19803614750520418
ADULT-ONSET DYSTONIA-PARKINSONISM	0.003981984	0.19803614750520418
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.003981984	0.19803614750520418
CHÉDIAK-HIGASHI SYNDROME	0.003981984	0.19803614750520418
49,XXXXY SYNDROME	0.003981984	0.19803614750520418
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.003981984	0.19803614750520418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.003981984	0.19803614750520418
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003981984	0.19803614750520418
PEROXISOME BIOGENESIS DISORDER 5B	0.003981984	0.19803614750520418
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.003981984	0.19803614750520418
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003981984	0.19803614750520418
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1883827665836962
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1883827665836962
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.1883827665836962
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1883827665836962
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1883827665836962
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1883827665836962
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1883827665836962
LYMPHOKINE DEFICIENCY	0.00378788	0.1883827665836962
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1883827665836962
BEETURIA	0.00378788	0.1883827665836962
HYPOASCORBEMIA	0.00378788	0.1883827665836962
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1883827665836962
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1883827665836962
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1883827665836962
REFSUM DISEASE	0.00378788	0.1883827665836962
CARBOXYLESTERASE 1	0.00378788	0.1883827665836962
ACETYLATION, SLOW	0.00378788	0.1883827665836962
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1883827665836962
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.1883827665836962
BARTTER SYNDROME	0.00378788	0.1883827665836962
ALKAPTONURIA	0.00378788	0.1883827665836962
PACMAN DYSPLASIA	0.00378788	0.1883827665836962
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.1883827665836962
OVARIAN CANCER	0.00378788	0.1883827665836962
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1883827665836962
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1883827665836962
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.1883827665836962
PARAOXONASE 1	0.00378788	0.1883827665836962
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1883827665836962
AREDYLD	0.00378788	0.1883827665836962
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1883827665836962
APOLIPOPROTEIN(A)	0.00378788	0.1883827665836962
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.1883827665836962
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.1883827665836962
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1883827665836962
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1883827665836962
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1883827665836962
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1883827665836962
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1883827665836962
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1883827665836962
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1883827665836962
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1883827665836962
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1883827665836962
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1883827665836962
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1883827665836962
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.1883827665836962
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1883827665836962
ZINC, ELEVATED PLASMA	0.00378788	0.1883827665836962
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1883827665836962
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.1883827665836962
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.1883827665836962
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1883827665836962
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1883827665836962
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1883827665836962
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1883827665836962
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1883827665836962
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1883827665836962
EPILEPSY-TELANGIECTASIA	0.00378788	0.1883827665836962
ETHANOLAMINOSIS	0.00378788	0.1883827665836962
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1883827665836962
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1883827665836962
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1883827665836962
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1883827665836962
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.1883827665836962
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1883827665836962
GAPO SYNDROME; GAPOS	0.00378788	0.1883827665836962
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1883827665836962
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1883827665836962
COUMARIN RESISTANCE	0.00378788	0.1883827665836962
HOOFT DISEASE	0.00378788	0.1883827665836962
FLOOD FACTOR DEFICIENCY	0.00378788	0.1883827665836962
GLOMUVENOUS MALFORMATIONS	0.00378788	0.1883827665836962
CEPHALIN LIPIDOSIS	0.00378788	0.1883827665836962
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1883827665836962
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.1883827665836962
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.1883827665836962
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1883827665836962
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1883827665836962
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.1883827665836962
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.1883827665836962
DERMATOLEUKODYSTROPHY	0.00378788	0.1883827665836962
GLUTATHIONE REDUCTASE	0.00378788	0.1883827665836962
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.1883827665836962
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1883827665836962
HYPERPROGLUCAGONEMIA	0.00378788	0.1883827665836962
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1883827665836962
HEINZ BODY ANEMIAS	0.00378788	0.1883827665836962
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1883827665836962
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1883827665836962
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1883827665836962
OSTEOGENIC SARCOMA	0.00378788	0.1883827665836962
CALVARIAL HYPEROSTOSIS	0.00378788	0.1883827665836962
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1883827665836962
LARON SYNDROME	0.00378788	0.1883827665836962
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1883827665836962
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1883827665836962
FINGERPRINT BODY MYOPATHY	0.00378788	0.1883827665836962
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00378788	0.1883827665836962
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1883827665836962
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1883827665836962
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1883827665836962
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.1883827665836962
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1883827665836962
SCHIZOPHRENIA 4	0.00378788	0.1883827665836962
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1883827665836962
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.1883827665836962
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.1883827665836962
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1883827665836962
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.1883827665836962
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1883827665836962
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1883827665836962
PENDRED SYNDROME	0.00378788	0.1883827665836962
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.1883827665836962
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1883827665836962
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1883827665836962
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1883827665836962
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.1883827665836962
PITUITARY DWARFISM IV	0.00378788	0.1883827665836962
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1883827665836962
ONCOCYTOMA	0.00378788	0.1883827665836962
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1883827665836962
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1883827665836962
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1883827665836962
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1883827665836962
XM SYSTEM	0.00378788	0.1883827665836962
DELETED IN AZOOSPERMIA	0.00378788	0.1883827665836962
PYGMY	0.00378788	0.1883827665836962
GONADOBLASTOMA	0.00378788	0.1883827665836962
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1883827665836962
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.1883827665836962
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1883827665836962
MACROCYTOSIS, FAMILIAL	0.00378788	0.1883827665836962
ICHTHYOSIS, X-LINKED	0.00378788	0.1883827665836962
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.1883827665836962
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1883827665836962
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.1883827665836962
PROGESTERONE RESISTANCE	0.00378788	0.1883827665836962
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1883827665836962
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1883827665836962
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.1883827665836962
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.1883827665836962
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1883827665836962
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1883827665836962
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.1883827665836962
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1883827665836962
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1883827665836962
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1883827665836962
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1883827665836962
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.1883827665836962
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.1883827665836962
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.1883827665836962
XANTHINURIA, TYPE I	0.00378788	0.1883827665836962
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.1883827665836962
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.1883827665836962
OSTEOMESOPYKNOSIS	0.00378788	0.1883827665836962
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1883827665836962
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.1883827665836962
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.1883827665836962
T-SUBSTANCE ANOMALY	0.00378788	0.1883827665836962
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1883827665836962
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1883827665836962
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1883827665836962
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1883827665836962
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.1883827665836962
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1883827665836962
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1883827665836962
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1883827665836962
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1883827665836962
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1883827665836962
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1883827665836962
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1883827665836962
NEONATAL ADRENOLEUKODYSTROPHY	0.00378788	0.1883827665836962
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1883827665836962
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1883827665836962
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1883827665836962
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.1883827665836962
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1883827665836962
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1883827665836962
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1883827665836962
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.1883827665836962
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1883827665836962
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1883827665836962
ALAND ISLAND EYE DISEASE	0.00378788	0.1883827665836962
OPTIC ATROPHY 2	0.00343643	0.1709040916214904
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00343643	0.1709040916214904
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.00343643	0.1709040916214904
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00343643	0.1709040916214904
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00343643	0.1709040916214904
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00343643	0.1709040916214904
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00343643	0.1709040916214904
BEHR SYNDROME	0.00343643	0.1709040916214904
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00343643	0.1709040916214904
TSH-SECRETING PITUITARY ADENOMA	0.00343643	0.1709040916214904
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00343643	0.1709040916214904
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00343643	0.1709040916214904
CEREBROTENDINOUS XANTHOMATOSIS	0.00343643	0.1709040916214904
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00343643	0.1709040916214904
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00343643	0.1709040916214904
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00343643	0.1709040916214904
KALLMANN SYNDROME	0.00343643	0.1709040916214904
DDOST-CDG	0.00343643	0.1709040916214904
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00343643	0.1709040916214904
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00343643	0.1709040916214904
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00343643	0.1709040916214904
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00343643	0.1709040916214904
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00343643	0.1709040916214904
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00343643	0.1709040916214904
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00343643	0.1709040916214904
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.00343643	0.1709040916214904
EPISODIC ATAXIA, TYPE 1; EA1	0.00343643	0.1709040916214904
SPASTIC PARAPARESIS AND DEAFNESS	0.00343643	0.1709040916214904
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00343643	0.1709040916214904
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00343643	0.1709040916214904
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 38	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00343643	0.1709040916214904
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00343643	0.1709040916214904
GM1 GANGLIOSIDOSIS	0.00343643	0.1709040916214904
GAUCHER DISEASE	0.00343643	0.1709040916214904
KUFOR-RAKEB SYNDROME	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 14	0.00343643	0.1709040916214904
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00343643	0.1709040916214904
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 18	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 21	0.00343643	0.1709040916214904
DYSTONIA 13, TORSION	0.00343643	0.1709040916214904
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.00343643	0.1709040916214904
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.00343643	0.1709040916214904
AMISH NEMALINE MYOPATHY	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 37	0.00343643	0.1709040916214904
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00343643	0.1709040916214904
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00343643	0.1709040916214904
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00343643	0.1709040916214904
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00343643	0.1709040916214904
PRIMARY DYSTONIA, DYT2 TYPE	0.00343643	0.1709040916214904
TYPHOID	0.00343643	0.1709040916214904
NIPAH VIRUS DISEASE	0.00343643	0.1709040916214904
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00343643	0.1709040916214904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00343643	0.1709040916214904
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00343643	0.1709040916214904
DYSTONIA 11, MYOCLONIC	0.00343643	0.1709040916214904
SÉZARY SYNDROME	0.00343643	0.1709040916214904
NON-FUNCTIONING PARAGANGLIOMA	0.00343643	0.1709040916214904
DYSTONIA 3, TORSION, X-LINKED	0.00343643	0.1709040916214904
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00343643	0.1709040916214904
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00343643	0.1709040916214904
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00343643	0.1709040916214904
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00343643	0.1709040916214904
CORTICOBASAL SYNDROME	0.00343643	0.1709040916214904
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00343643	0.1709040916214904
MOHR-TRANEBJAERG SYNDROME	0.00343643	0.1709040916214904
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00343643	0.1709040916214904
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00343643	0.1709040916214904
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00343643	0.1709040916214904
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.00343643	0.1709040916214904
ATAXIA WITH VITAMIN E DEFICIENCY	0.00343643	0.1709040916214904
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00343643	0.1709040916214904
TETANUS	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00343643	0.1709040916214904
MERCURY POISONING	0.00343643	0.1709040916214904
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00343643	0.1709040916214904
ATAXIA-TELANGIECTASIA	0.00343643	0.1709040916214904
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.00343643	0.1709040916214904
PERRY SYNDROME	0.00343643	0.1709040916214904
ACERULOPLASMINEMIA	0.00343643	0.1709040916214904
O'SULLIVAN-MCLEOD SYNDROME	0.00343643	0.1709040916214904
ENCEPHALITIS LETHARGICA	0.00343643	0.1709040916214904
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00343643	0.1709040916214904
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00343643	0.1709040916214904
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00343643	0.1709040916214904
OROFACIODIGITAL SYNDROME TYPE 1	0.00343643	0.1709040916214904
MYOCLONIC-ATONIC EPILEPSY	0.00343643	0.1709040916214904
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.00343643	0.1709040916214904
ALEXANDER DISEASE	0.00343643	0.1709040916214904
SNEDDON SYNDROME	0.00343643	0.1709040916214904
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00343643	0.1709040916214904
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00343643	0.1709040916214904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00343643	0.1709040916214904
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00343643	0.1709040916214904
PARKINSON DISEASE 21; PARK21	0.00343643	0.1709040916214904
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00343643	0.1709040916214904
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.00343643	0.1709040916214904
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00343643	0.1709040916214904
PRIMARY ORTHOSTATIC TREMOR	0.00343643	0.1709040916214904
CYSTATHIONINURIA	0.00343643	0.1709040916214904
SIALIDOSIS TYPE 1	0.00343643	0.1709040916214904
THYROTOXIC PERIODIC PARALYSIS	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 42	0.00343643	0.1709040916214904
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00343643	0.1709040916214904
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00343643	0.1709040916214904
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00343643	0.1709040916214904
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00343643	0.1709040916214904
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00343643	0.1709040916214904
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00343643	0.1709040916214904
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00343643	0.1709040916214904
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 31	0.00343643	0.1709040916214904
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00343643	0.1709040916214904
PROGRESSIVE SUPRANUCLEAR PALSY	0.00343643	0.1709040916214904
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00343643	0.1709040916214904
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.00343643	0.1709040916214904
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00343643	0.1709040916214904
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00343643	0.1709040916214904
4Q21 MICRODELETION SYNDROME	0.00343643	0.1709040916214904
SCRUB TYPHUS	0.00343643	0.1709040916214904
CEREBELLAR HYPOPLASIA	0.00343643	0.1709040916214904
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00343643	0.1709040916214904
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00343643	0.1709040916214904
YOUNG-ONSET PARKINSON DISEASE	0.00343643	0.1709040916214904
WILSON DISEASE	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00343643	0.1709040916214904
CHOREOACANTHOCYTOSIS	0.00343643	0.1709040916214904
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00343643	0.1709040916214904
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00343643	0.1709040916214904
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00343643	0.1709040916214904
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001301984	0.06475161514295782
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.06475161514295782
MICRO SYNDROME	0.001301984	0.06475161514295782
BOHRING-OPITZ SYNDROME	0.001301984	0.06475161514295782
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.06475161514295782
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001301984	0.06475161514295782
DISTAL TRISOMY 17Q	0.001301984	0.06475161514295782
PETERS PLUS SYNDROME	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001301984	0.06475161514295782
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.06475161514295782
TRISOMY 18	0.001301984	0.06475161514295782
SSR4-CDG	0.001301984	0.06475161514295782
EAR-PATELLA-SHORT STATURE SYNDROME	0.001301984	0.06475161514295782
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.001301984	0.06475161514295782
1Q21.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.001301984	0.06475161514295782
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001301984	0.06475161514295782
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.06475161514295782
15Q14 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
KOOLEN-DE VRIES SYNDROME	0.001301984	0.06475161514295782
EMANUEL SYNDROME	0.001301984	0.06475161514295782
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.06475161514295782
MONOSOMY 9P	0.001301984	0.06475161514295782
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001301984	0.06475161514295782
ALG3-CDG	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001301984	0.06475161514295782
STT3A-CDG	0.001301984	0.06475161514295782
MIETENS SYNDROME	0.001301984	0.06475161514295782
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001301984	0.06475161514295782
ALPERS-HUTTENLOCHER SYNDROME	0.001301984	0.06475161514295782
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001301984	0.06475161514295782
LIG4 SYNDROME	0.001301984	0.06475161514295782
STT3B-CDG	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001301984	0.06475161514295782
MOSAIC TRISOMY 9	0.001301984	0.06475161514295782
2Q31.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
1Q44 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.06475161514295782
8P23.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.06475161514295782
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001301984	0.06475161514295782
RUBINSTEIN-TAYBI SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001301984	0.06475161514295782
20Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.001301984	0.06475161514295782
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001301984	0.06475161514295782
CK SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001301984	0.06475161514295782
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001301984	0.06475161514295782
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001301984	0.06475161514295782
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001301984	0.06475161514295782
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.06475161514295782
DISTAL MONOSOMY 1Q	0.001301984	0.06475161514295782
8P11.2 DELETION SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.001301984	0.06475161514295782
MONOSOMY 13Q34	0.001301984	0.06475161514295782
DUANE RETRACTION SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001301984	0.06475161514295782
KBG SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.001301984	0.06475161514295782
PHACE SYNDROME	0.001301984	0.06475161514295782
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001301984	0.06475161514295782
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.06475161514295782
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001301984	0.06475161514295782
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.001301984	0.06475161514295782
3Q29 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
19P13.12 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.06475161514295782
6Q25 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.001301984	0.06475161514295782
TRISOMY 9P	0.001301984	0.06475161514295782
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001301984	0.06475161514295782
RIDDLE SYNDROME	0.001301984	0.06475161514295782
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001301984	0.06475161514295782
DISTAL MONOSOMY 12Q	0.001301984	0.06475161514295782
DISTAL MONOSOMY 10Q	0.001301984	0.06475161514295782
1P36 DELETION SYNDROME	0.001301984	0.06475161514295782
MONOSOMY 18Q	0.001301984	0.06475161514295782
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001301984	0.06475161514295782
MONOSOMY 18P	0.001301984	0.06475161514295782
DISTAL MONOSOMY 15Q	0.001301984	0.06475161514295782
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.06475161514295782
TOLUENE EMBRYOPATHY	0.001301984	0.06475161514295782
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001301984	0.06475161514295782
COHEN SYNDROME	0.001301984	0.06475161514295782
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.06475161514295782
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001301984	0.06475161514295782
BRESEK SYNDROME	0.001301984	0.06475161514295782
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001301984	0.06475161514295782
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.06475161514295782
COFFIN-SIRIS SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.001301984	0.06475161514295782
GENITOPATELLAR SYNDROME	0.001301984	0.06475161514295782
MARINESCO-SJÖGREN SYNDROME	0.001301984	0.06475161514295782
RING CHROMOSOME 22 SYNDROME	0.001301984	0.06475161514295782
RING CHROMOSOME 12 SYNDROME	0.001301984	0.06475161514295782
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001301984	0.06475161514295782
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001301984	0.06475161514295782
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
FETAL TRIMETHADIONE SYNDROME	0.001301984	0.06475161514295782
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.06475161514295782
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.06475161514295782
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.06475161514295782
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001301984	0.06475161514295782
6Q16 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001301984	0.06475161514295782
WALKER-WARBURG SYNDROME	0.001301984	0.06475161514295782
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001301984	0.06475161514295782
PEHO SYNDROME	0.001301984	0.06475161514295782
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.06475161514295782
DPAGT1-CDG	0.001301984	0.06475161514295782
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001301984	0.06475161514295782
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.001301984	0.06475161514295782
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001301984	0.06475161514295782
PITT-HOPKINS SYNDROME	0.001301984	0.06475161514295782
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001301984	0.06475161514295782
ALG11-CDG	0.001301984	0.06475161514295782
MEVALONIC ACIDURIA	0.001301984	0.06475161514295782
16P13.2 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
CONGENITAL VARICELLA SYNDROME	0.001301984	0.06475161514295782
CONGENITAL TOXOPLASMOSIS	0.001301984	0.06475161514295782
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
MARDEN-WALKER SYNDROME	0.001301984	0.06475161514295782
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
22Q11.2 DELETION SYNDROME	0.001301984	0.06475161514295782
ROBERTS SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.001301984	0.06475161514295782
17Q21.31 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.06475161514295782
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001301984	0.06475161514295782
KLEEFSTRA SYNDROME	0.001301984	0.06475161514295782
MATERNAL PHENYLKETONURIA	0.001301984	0.06475161514295782
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001301984	0.06475161514295782
FILIPPI SYNDROME	0.001301984	0.06475161514295782
19P13.3 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.06475161514295782
2P15P16.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.06475161514295782
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.06475161514295782
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.06475161514295782
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.001301984	0.06475161514295782
HYPERTRICHOSIS CUBITI	0.001301984	0.06475161514295782
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.001301984	0.06475161514295782
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
TRISOMY 17P	0.001301984	0.06475161514295782
16P13.11 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.06475161514295782
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.06475161514295782
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001301984	0.06475161514295782
DOORS SYNDROME	0.001301984	0.06475161514295782
FANCONI ANEMIA	0.001301984	0.06475161514295782
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.06475161514295782
RUVALCABA SYNDROME	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001301984	0.06475161514295782
17Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001301984	0.06475161514295782
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001301984	0.06475161514295782
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001301984	0.06475161514295782
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.06475161514295782
LATHOSTEROLOSIS	0.001301984	0.06475161514295782
MULTIPLE SULFATASE DEFICIENCY	0.001301984	0.06475161514295782
OROFACIODIGITAL SYNDROME TYPE 4	0.001301984	0.06475161514295782
OKAMOTO SYNDROME	0.001301984	0.06475161514295782
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001301984	0.06475161514295782
HOLMES-GANG SYNDROME	0.001301984	0.06475161514295782
15Q24 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
OCULO-PALATO-CEREBRAL SYNDROME	0.001301984	0.06475161514295782
SMITH-LEMLI-OPITZ SYNDROME	0.001301984	0.06475161514295782
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001301984	0.06475161514295782
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001301984	0.06475161514295782
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001301984	0.06475161514295782
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001301984	0.06475161514295782
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001301984	0.06475161514295782
COG4-CDG	0.001301984	0.06475161514295782
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001301984	0.06475161514295782
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.06475161514295782
COFFIN-SIRIS SYNDROME 3; CSS3	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.06475161514295782
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001301984	0.06475161514295782
SECKEL SYNDROME 8; SCKL8	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.06475161514295782
AICARDI-GOUTIERES SYNDROME 7	0.001301984	0.06475161514295782
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001301984	0.06475161514295782
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.06475161514295782
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001301984	0.06475161514295782
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001301984	0.06475161514295782
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001301984	0.06475161514295782
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001301984	0.06475161514295782
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.06475161514295782
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.06475161514295782
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001301984	0.06475161514295782
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001301984	0.06475161514295782
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001301984	0.06475161514295782
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001301984	0.06475161514295782
MACDERMOT-WINTER SYNDROME	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001301984	0.06475161514295782
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001301984	0.06475161514295782
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001301984	0.06475161514295782
RAINE SYNDROME	0.001301984	0.06475161514295782
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.06475161514295782
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.06475161514295782
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.06475161514295782
LISSENCEPHALY 2; LIS2	0.001301984	0.06475161514295782
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001301984	0.06475161514295782
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001301984	0.06475161514295782
MUCOLIPIDOSIS IV; ML4	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
ALAZAMI SYNDROME; ALAZS	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.06475161514295782
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001301984	0.06475161514295782
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001301984	0.06475161514295782
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.06475161514295782
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.06475161514295782
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001301984	0.06475161514295782
ALAZAMI-YUAN SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001301984	0.06475161514295782
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001301984	0.06475161514295782
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.06475161514295782
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001301984	0.06475161514295782
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001301984	0.06475161514295782
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001301984	0.06475161514295782
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001301984	0.06475161514295782
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.06475161514295782
COFFIN-SIRIS SYNDROME 5	0.001301984	0.06475161514295782
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.06475161514295782
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001301984	0.06475161514295782
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.06475161514295782
LISSENCEPHALY 8; LIS8	0.001301984	0.06475161514295782
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001301984	0.06475161514295782
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.06475161514295782
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001301984	0.06475161514295782
HEART AND BRAIN MALFORMATION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001301984	0.06475161514295782
RING CHROMOSOME 14 SYNDROME	0.001301984	0.06475161514295782
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001301984	0.06475161514295782
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001301984	0.06475161514295782
AL-RAQAD SYNDROME; ARS	0.001301984	0.06475161514295782
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.06475161514295782
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.06475161514295782
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001301984	0.06475161514295782
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.06475161514295782
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.06475161514295782
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
C SYNDROME	0.001301984	0.06475161514295782
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001301984	0.06475161514295782
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001301984	0.06475161514295782
SECKEL SYNDROME 9; SCKL9	0.001301984	0.06475161514295782
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.06475161514295782
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001301984	0.06475161514295782
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.06475161514295782
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.06475161514295782
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001301984	0.06475161514295782
COFFIN-SIRIS SYNDROME 4; CSS4	0.001301984	0.06475161514295782
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001301984	0.06475161514295782
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001301984	0.06475161514295782
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001301984	0.06475161514295782
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001301984	0.06475161514295782
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.06475161514295782
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.001301984	0.06475161514295782
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001301984	0.06475161514295782
GOLDBERG-SHPRINTZEN SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 5; HPE5	0.001301984	0.06475161514295782
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.001301984	0.06475161514295782
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001301984	0.06475161514295782
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001301984	0.06475161514295782
MEVALONIC ACIDURIA; MEVA	0.001301984	0.06475161514295782
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001301984	0.06475161514295782
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001301984	0.06475161514295782
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.06475161514295782
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001301984	0.06475161514295782
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001301984	0.06475161514295782
BOHRING-OPITZ SYNDROME	0.001301984	0.06475161514295782
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.06475161514295782
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001301984	0.06475161514295782
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.06475161514295782
LOWRY-MACLEAN SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001301984	0.06475161514295782
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.06475161514295782
WIEACKER-WOLFF SYNDROME	0.001301984	0.06475161514295782
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001301984	0.06475161514295782
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001301984	0.06475161514295782
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001301984	0.06475161514295782
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001301984	0.06475161514295782
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.06475161514295782
PHELAN-MCDERMID SYNDROME	0.001301984	0.06475161514295782
LIG4 SYNDROME	0.001301984	0.06475161514295782
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.06475161514295782
CHROMOSOME 1P36 DELETION SYNDROME	0.001301984	0.06475161514295782
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001301984	0.06475161514295782
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.001301984	0.06475161514295782
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001301984	0.06475161514295782
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.06475161514295782
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.06475161514295782
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001301984	0.06475161514295782
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.06475161514295782
LISSENCEPHALY 4	0.001301984	0.06475161514295782
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001301984	0.06475161514295782
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.06475161514295782
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001301984	0.06475161514295782
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
ROTHMUND-THOMSON SYNDROME	0.001301984	0.06475161514295782
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001301984	0.06475161514295782
ADAMS-OLIVER SYNDROME 2; AOS2	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 11	0.001301984	0.06475161514295782
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.06475161514295782
PETERS-PLUS SYNDROME; PTRPLS	0.001301984	0.06475161514295782
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001301984	0.06475161514295782
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001301984	0.06475161514295782
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001301984	0.06475161514295782
BARATELA-SCOTT SYNDROME	0.001301984	0.06475161514295782
OGDEN SYNDROME; OGDNS	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001301984	0.06475161514295782
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.06475161514295782
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001301984	0.06475161514295782
GLASS SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001301984	0.06475161514295782
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001301984	0.06475161514295782
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001301984	0.06475161514295782
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.06475161514295782
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001301984	0.06475161514295782
WITTEVEEN-KOLK SYNDROME	0.001301984	0.06475161514295782
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.06475161514295782
HADZISELIMOVIC SYNDROME	0.001301984	0.06475161514295782
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001301984	0.06475161514295782
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.06475161514295782
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.06475161514295782
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001301984	0.06475161514295782
BETA-UREIDOPROPIONASE DEFICIENCY	0.001301984	0.06475161514295782
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.06475161514295782
WARSAW BREAKAGE SYNDROME; WABS	0.001301984	0.06475161514295782
OPTIC ATROPHY 11; OPA11	0.001301984	0.06475161514295782
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.06475161514295782
ADAMS-OLIVER SYNDROME 1; AOS1	0.001301984	0.06475161514295782
XQ28 (MECP2) DUPLICATION	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001301984	0.06475161514295782
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001301984	0.06475161514295782
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001301984	0.06475161514295782
COFFIN-SIRIS SYNDROME 1; CSS1	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001301984	0.06475161514295782
KABUKI SYNDROME 1	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.001301984	0.06475161514295782
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001301984	0.06475161514295782
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001301984	0.06475161514295782
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001301984	0.06475161514295782
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.06475161514295782
MYHRE SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001301984	0.06475161514295782
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001301984	0.06475161514295782
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001301984	0.06475161514295782
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001301984	0.06475161514295782
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001301984	0.06475161514295782
ADENYLOSUCCINASE DEFICIENCY	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.06475161514295782
KLEEFSTRA SYNDROME 2; KLEFS2	0.001301984	0.06475161514295782
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.001301984	0.06475161514295782
15Q13.3 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001301984	0.06475161514295782
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001301984	0.06475161514295782
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.06475161514295782
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001301984	0.06475161514295782
KBG SYNDROME	0.001301984	0.06475161514295782
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.001301984	0.06475161514295782
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 2; HPE2	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001301984	0.06475161514295782
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001301984	0.06475161514295782
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001301984	0.06475161514295782
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001301984	0.06475161514295782
CHROMOSOME 1P35 DELETION SYNDROME	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001301984	0.06475161514295782
3Q29 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001301984	0.06475161514295782
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.06475161514295782
RHIZOMELIC SYNDROME	0.00075643	0.03761955925924404
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00075643	0.03761955925924404
MECKEL SYNDROME	0.00075643	0.03761955925924404
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.03761955925924404
LEUKOCYTE ADHESION DEFICIENCY	0.00075643	0.03761955925924404
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.03761955925924404
CRI-DU-CHAT SYNDROME	0.00075643	0.03761955925924404
PERRAULT SYNDROME 3	0.00075643	0.03761955925924404
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.03761955925924404
TEEBI-SHALTOUT SYNDROME; TBSH	0.00075643	0.03761955925924404
ROBERTS SYNDROME; RBS	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00075643	0.03761955925924404
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00075643	0.03761955925924404
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.03761955925924404
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.00075643	0.03761955925924404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00075643	0.03761955925924404
OLIVER SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00075643	0.03761955925924404
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.03761955925924404
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.03761955925924404
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.03761955925924404
HYPERREFLEXIA	0.00075643	0.03761955925924404
SCHISIS ASSOCIATION	0.00075643	0.03761955925924404
ACROOTOOCULAR SYNDROME	0.00075643	0.03761955925924404
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.03761955925924404
PSEUDOPROGERIA SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00075643	0.03761955925924404
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.03761955925924404
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.03761955925924404
SECKEL SYNDROME 4	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.03761955925924404
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.03761955925924404
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.03761955925924404
MUCOLIPIDOSIS TYPE IV	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.03761955925924404
SECKEL SYNDROME 5; SCKL5	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.03761955925924404
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.03761955925924404
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.03761955925924404
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.03761955925924404
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.03761955925924404
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00075643	0.03761955925924404
RENAL TUBULAR DYSGENESIS	0.00075643	0.03761955925924404
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.03761955925924404
SATOYOSHI SYNDROME	0.00075643	0.03761955925924404
MICROPHTHALMIA, LENZ TYPE	0.00075643	0.03761955925924404
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.03761955925924404
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00075643	0.03761955925924404
20P13 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
HEREDITARY METHEMOGLOBINEMIA	0.00075643	0.03761955925924404
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.03761955925924404
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00075643	0.03761955925924404
FILIPPI SYNDROME; FLPIS	0.00075643	0.03761955925924404
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00075643	0.03761955925924404
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00075643	0.03761955925924404
POLAND SYNDROME	0.00075643	0.03761955925924404
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.03761955925924404
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.03761955925924404
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.03761955925924404
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.03761955925924404
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.03761955925924404
ANGELMAN SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00075643	0.03761955925924404
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.03761955925924404
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.03761955925924404
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.03761955925924404
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.03761955925924404
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.03761955925924404
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00075643	0.03761955925924404
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.03761955925924404
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.03761955925924404
RING CHROMOSOME 13 SYNDROME	0.00075643	0.03761955925924404
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00075643	0.03761955925924404
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00075643	0.03761955925924404
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.03761955925924404
NON-DISTAL MONOSOMY 20Q	0.00075643	0.03761955925924404
MARDEN-WALKER SYNDROME	0.00075643	0.03761955925924404
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.03761955925924404
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00075643	0.03761955925924404
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.03761955925924404
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.03761955925924404
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.03761955925924404
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00075643	0.03761955925924404
NEU-LAXOVA SYNDROME	0.00075643	0.03761955925924404
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.03761955925924404
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00075643	0.03761955925924404
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00075643	0.03761955925924404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.03761955925924404
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.03761955925924404
TRISOMY 8P	0.00075643	0.03761955925924404
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00075643	0.03761955925924404
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.03761955925924404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00075643	0.03761955925924404
MICROTRIPLICATION 11Q24.1	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.03761955925924404
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00075643	0.03761955925924404
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.03761955925924404
PIEBALDISM	0.00075643	0.03761955925924404
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.03761955925924404
NEVUS COMEDONICUS SYNDROME	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.03761955925924404
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.03761955925924404
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.03761955925924404
CONGENITAL RUBELLA SYNDROME	0.00075643	0.03761955925924404
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.03761955925924404
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
JACOBSEN SYNDROME	0.00075643	0.03761955925924404
PRIMARY CUTIS VERTICIS GYRATA	0.00075643	0.03761955925924404
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.03761955925924404
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.03761955925924404
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.03761955925924404
MICROFORM HOLOPROSENCEPHALY	0.00075643	0.03761955925924404
3MC SYNDROME 1	0.00075643	0.03761955925924404
SECKEL SYNDROME 7; SCKL7	0.00075643	0.03761955925924404
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00075643	0.03761955925924404
MONOSOMY 5P	0.00075643	0.03761955925924404
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00075643	0.03761955925924404
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.03761955925924404
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.03761955925924404
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00075643	0.03761955925924404
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00075643	0.03761955925924404
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.03761955925924404
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.03761955925924404
XP22.13P22.2 DUPLICATION SYNDROME	0.00075643	0.03761955925924404
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.03761955925924404
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.03761955925924404
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.03761955925924404
ANGELMAN SYNDROME (TYPE 2)	0.00075643	0.03761955925924404
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00075643	0.03761955925924404
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.03761955925924404
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.03761955925924404
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00075643	0.03761955925924404
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.03761955925924404
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.03761955925924404
LATHOSTEROLOSIS	0.00075643	0.03761955925924404
INCONTINENTIA PIGMENTI; IP	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00075643	0.03761955925924404
SECKEL SYNDROME 2; SCKL2	0.00075643	0.03761955925924404
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00075643	0.03761955925924404
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.03761955925924404
MENKES DISEASE	0.00075643	0.03761955925924404
GAUCHER DISEASE, PERINATAL LETHAL	0.00075643	0.03761955925924404
AICARDI SYNDROME; AIC	0.00075643	0.03761955925924404
COFFIN-LOWRY SYNDROME; CLS	0.00075643	0.03761955925924404
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.03761955925924404
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.03761955925924404
PAGOD SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.03761955925924404
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
15Q24 RECURRENT MICRODELETION SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.03761955925924404
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00075643	0.03761955925924404
MASA SYNDROME	0.00075643	0.03761955925924404
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.03761955925924404
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.03761955925924404
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00075643	0.03761955925924404
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.03761955925924404
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00075643	0.03761955925924404
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.03761955925924404
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.03761955925924404
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.03761955925924404
ANGELMAN SYNDROME (TYPE 1)	0.00075643	0.03761955925924404
PELIZAEUS-MERZBACHER DISEASE	0.00075643	0.03761955925924404
WARBURG MICRO SYNDROME 1	0.00075643	0.03761955925924404
CYCLIC VOMITING SYNDROME	0.00075643	0.03761955925924404
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00075643	0.03761955925924404
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.03761955925924404
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.03761955925924404
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.03761955925924404
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00075643	0.03761955925924404
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.03761955925924404
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.03761955925924404
KEPPEN-LUBINSKY SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00075643	0.03761955925924404
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.03761955925924404
ERMINE PHENOTYPE	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.03761955925924404
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.03761955925924404
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.03761955925924404
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.03761955925924404
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.03761955925924404
RENPENNING SYNDROME 1; RENS1	0.00075643	0.03761955925924404
MICROHYDRANENCEPHALY; MHAC	0.00075643	0.03761955925924404
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.03761955925924404
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.03761955925924404
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00075643	0.03761955925924404
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00075643	0.03761955925924404
MICROPHTHALMIA, SYNDROMIC 1	0.00075643	0.03761955925924404
TEMPLE-BARAITSER SYNDROME	0.00075643	0.03761955925924404
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.03761955925924404
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.03761955925924404
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00075643	0.03761955925924404
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.03761955925924404
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.03761955925924404
OROFACIODIGITAL SYNDROME I; OFD1	0.00075643	0.03761955925924404
PAINE SYNDROME	0.00075643	0.03761955925924404
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.03761955925924404
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.03761955925924404
WIEDEMANN-STEINER SYNDROME	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.03761955925924404
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00075643	0.03761955925924404
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.03761955925924404
FACIOCARDIOMELIC SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.03761955925924404
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.03761955925924404
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.03761955925924404
ALLAN-HERNDON-DUDLEY SYNDROME	0.00075643	0.03761955925924404
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.03761955925924404
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00075643	0.03761955925924404
TETRAPLOIDY	0.00075643	0.03761955925924404
DUPLICATION/INVERSION 15Q11	0.00075643	0.03761955925924404
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.03761955925924404
TETRASOMY 18P	0.00075643	0.03761955925924404
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00075643	0.03761955925924404
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00075643	0.03761955925924404
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00075643	0.03761955925924404
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.03761955925924404
CORNELIA DE LANGE SYNDROME 1	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.03761955925924404
STIMMLER SYNDROME	0.00075643	0.03761955925924404
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.03761955925924404
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.03761955925924404
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00075643	0.03761955925924404
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00075643	0.03761955925924404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.03761955925924404
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00075643	0.03761955925924404
RENPENNING SYNDROME	0.00075643	0.03761955925924404
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.03761955925924404
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.03761955925924404
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.03761955925924404
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00075643	0.03761955925924404
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00075643	0.03761955925924404
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.03761955925924404
PITT-HOPKINS SYNDROME	0.00075643	0.03761955925924404
AICARDI SYNDROME	0.00075643	0.03761955925924404
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.03761955925924404
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00075643	0.03761955925924404
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.03761955925924404
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.03761955925924404
KLEEFSTRA SYNDROME	0.00075643	0.03761955925924404
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.03761955925924404
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.03761955925924404
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, X-LINKED 102	0.00075643	0.03761955925924404
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.03761955925924404
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.03761955925924404
FONTAINE PROGEROID SYNDROME; FPS	0.00075643	0.03761955925924404
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.00075643	0.03761955925924404
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.03761955925924404
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00075643	0.03761955925924404
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.03761955925924404
MMEP SYNDROME	0.00075643	0.03761955925924404
WEAVER-WILLIAMS SYNDROME	0.00075643	0.03761955925924404
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00075643	0.03761955925924404
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00075643	0.03761955925924404
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.03761955925924404
WORSTER-DROUGHT SYNDROME	0.00075643	0.03761955925924404
XK APROSENCEPHALY SYNDROME	0.00075643	0.03761955925924404
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.03761955925924404
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00075643	0.03761955925924404
BRANCHIOOCULOFACIAL SYNDROME	0.00075643	0.03761955925924404
DESMOSTEROLOSIS	0.00075643	0.03761955925924404
LISSENCEPHALY 3; LIS3	0.00075643	0.03761955925924404
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
WOLF-HIRSCHHORN SYNDROME	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 1; MGORS1	0.00075643	0.03761955925924404
2Q23.1 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.03761955925924404
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.03761955925924404
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.03761955925924404
OTOMANDIBULAR SYNDROME	0.00075643	0.03761955925924404
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.03761955925924404
CAMOS SYNDROME	0.00075643	0.03761955925924404
5Q35 MICRODUPLICATION SYNDROME	0.00075643	0.03761955925924404
LOWRY-WOOD SYNDROME	0.00075643	0.03761955925924404
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.03761955925924404
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00075643	0.03761955925924404
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.03761955925924404
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.03761955925924404
ISOTRETINOIN-LIKE SYNDROME	0.00075643	0.03761955925924404
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.03761955925924404
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.00075643	0.03761955925924404
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.03761955925924404
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.03761955925924404
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.03761955925924404
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.03761955925924404
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.03761955925924404
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00075643	0.03761955925924404
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00075643	0.03761955925924404
CROME SYNDROME	0.00075643	0.03761955925924404
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.03761955925924404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00075643	0.03761955925924404
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.03761955925924404
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00075643	0.03761955925924404
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.03761955925924404
SECKEL SYNDROME 1; SCKL1	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.03761955925924404
BARDET-BIEDL SYNDROME 20	0.00075643	0.03761955925924404
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00075643	0.03761955925924404
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00075643	0.03761955925924404
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00075643	0.03761955925924404
TRISOMY 4P	0.00075643	0.03761955925924404
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.03761955925924404
FEINGOLD SYNDROME	0.00075643	0.03761955925924404
SECKEL SYNDROME	0.00075643	0.03761955925924404
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.03761955925924404
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.03761955925924404
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.03761955925924404
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.03761955925924404
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.03761955925924404
BRANCHIOSKELETOGENITAL SYNDROME	0.00075643	0.03761955925924404
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.03761955925924404
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.03761955925924404
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.03761955925924404
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.03761955925924404
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.03761955925924404
SANJAD-SAKATI SYNDROME	0.00075643	0.03761955925924404
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.03761955925924404
KABUKI SYNDROME	0.00075643	0.03761955925924404
JUNG SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.03761955925924404
JUBERG-HAYWARD SYNDROME	0.00075643	0.03761955925924404
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.03761955925924404
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.03761955925924404
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.03761955925924404
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.03761955925924404
SJÖGREN-LARSSON SYNDROME	0.00075643	0.03761955925924404
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00075643	0.03761955925924404
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.03761955925924404
COHEN SYNDROME	0.00075643	0.03761955925924404
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.03761955925924404
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00075643	0.03761955925924404
BLOOM SYNDROME	0.00075643	0.03761955925924404
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.03761955925924404
BOWEN-CONRADI SYNDROME	0.00075643	0.03761955925924404
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00075643	0.03761955925924404
GMS SYNDROME	0.00075643	0.03761955925924404
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.03761955925924404
BANGSTAD SYNDROME	0.00075643	0.03761955925924404
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00075643	0.03761955925924404
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.03761955925924404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00075643	0.03761955925924404
HALL-RIGGS SYNDROME	0.00075643	0.03761955925924404
CORNELIA DE LANGE SYNDROME	0.00075643	0.03761955925924404
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.03761955925924404
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00075643	0.03761955925924404
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00075643	0.03761955925924404
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.03761955925924404
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.03761955925924404
TRIPLE A SYNDROME	0.00075643	0.03761955925924404
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.03761955925924404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00075643	0.03761955925924404
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.03761955925924404
FRASER SYNDROME	0.00075643	0.03761955925924404
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.03761955925924404
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.03761955925924404
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.03761955925924404
MARTSOLF SYNDROME	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00075643	0.03761955925924404
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.03761955925924404
HALLERMANN-STREIFF SYNDROME	0.00075643	0.03761955925924404
HARROD SYNDROME	0.00075643	0.03761955925924404
DIABETIC EMBRYOPATHY	0.00075643	0.03761955925924404
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.03761955925924404
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.03761955925924404
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.03761955925924404
FETAL METHYLMERCURY SYNDROME	0.00075643	0.03761955925924404
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.03761955925924404
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.03761955925924404
YUNIS-VARON SYNDROME	0.00075643	0.03761955925924404
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.03761955925924404
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.03761955925924404
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00075643	0.03761955925924404
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.03761955925924404
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00075643	0.03761955925924404
CHRISTIANSON SYNDROME	0.00075643	0.03761955925924404
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00075643	0.03761955925924404
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00075643	0.03761955925924404
WAGR SYNDROME	0.00075643	0.03761955925924404
MEHMO SYNDROME	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.03761955925924404
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00075643	0.03761955925924404
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.03761955925924404
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.03761955925924404
COFFIN-LOWRY SYNDROME	0.00075643	0.03761955925924404
CHARGE SYNDROME	0.00075643	0.03761955925924404
MOWAT-WILSON SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.03761955925924404
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00075643	0.03761955925924404
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00075643	0.03761955925924404
BOWEN-CONRADI SYNDROME	0.00075643	0.03761955925924404
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.03761955925924404
FANCONI ANEMIA	0.00075643	0.03761955925924404
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
DISTAL MONOSOMY 3P	0.00075643	0.03761955925924404
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.03761955925924404
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.03761955925924404
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.03761955925924404
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.03761955925924404
SECKEL SYNDROME 10; SCKL10	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.03761955925924404
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00075643	0.03761955925924404
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.03761955925924404
DISTAL MONOSOMY 17Q	0.00075643	0.03761955925924404
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.03761955925924404
MONOSOMY 22	0.00075643	0.03761955925924404
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.03761955925924404
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.03761955925924404
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00075643	0.03761955925924404
RING CHROMOSOME 7 SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00075643	0.03761955925924404
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.03761955925924404
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.03761955925924404
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.03761955925924404
DISTAL MONOSOMY 13Q	0.00075643	0.03761955925924404
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00075643	0.03761955925924404
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00075643	0.03761955925924404
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00075643	0.03761955925924404
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00075643	0.03761955925924404
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.03761955925924404
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.03761955925924404
CRANIOFRONTONASAL DYSPLASIA	0.00075643	0.03761955925924404
SUPRABULBAR PARESIS, CONGENITAL	0.00075643	0.03761955925924404
RUVALCABA SYNDROME	0.00075643	0.03761955925924404
RETT SYNDROME	0.00075643	0.03761955925924404
14Q12 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
LAMBOTTE SYNDROME	0.00075643	0.03761955925924404
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00075643	0.03761955925924404
STROMME SYNDROME; STROMS	0.00075643	0.03761955925924404
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.03761955925924404
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00075643	0.03761955925924404
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00075643	0.03761955925924404
ANE SYNDROME	0.00075643	0.03761955925924404
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.03761955925924404
DISTAL MONOSOMY 10P	0.00075643	0.03761955925924404
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.03761955925924404
MOYNAHAN SYNDROME	0.00075643	0.03761955925924404
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.03761955925924404
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.03761955925924404
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00075643	0.03761955925924404
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00075643	0.03761955925924404
MONOSOMY 13Q14	0.00075643	0.03761955925924404
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM	0.00075643	0.03761955925924404
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.03761955925924404
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.03761955925924404
LOWRY-MACLEAN SYNDROME	0.00075643	0.03761955925924404
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.03761955925924404
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.03761955925924404
MOWAT-WILSON SYNDROME; MOWS	0.00075643	0.03761955925924404
NON-DISTAL TRISOMY 13Q	0.00075643	0.03761955925924404
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.03761955925924404
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.03761955925924404
ZELLWEGER SYNDROME	0.00075643	0.03761955925924404
RING CHROMOSOME 6 SYNDROME	0.00075643	0.03761955925924404
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.03761955925924404
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.03761955925924404
VELOCARDIOFACIAL SYNDROME	0.00075643	0.03761955925924404
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.03761955925924404
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00075643	0.03761955925924404
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.03761955925924404
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00075643	0.03761955925924404
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.03761955925924404
NON-DISTAL TRISOMY 10Q	0.00075643	0.03761955925924404
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.03761955925924404
DPM1-CDG	0.00075643	0.03761955925924404
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00075643	0.03761955925924404
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.03761955925924404
SHPRINTZEN-GOLDBERG SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.03761955925924404
HALLERMANN-STREIFF SYNDROME; HSS	0.00075643	0.03761955925924404
BLOOM SYNDROME	0.00075643	0.03761955925924404
ADDUCTED THUMBS SYNDROME	0.00075643	0.03761955925924404
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.03761955925924404
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00075643	0.03761955925924404
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.03761955925924404
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00075643	0.03761955925924404
RING CHROMOSOME 1 SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00075643	0.03761955925924404
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00075643	0.03761955925924404
TRISOMY 18P	0.00075643	0.03761955925924404
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.03761955925924404
DISTAL TRISOMY 15Q	0.00075643	0.03761955925924404
MECKEL SYNDROME 12; MKS12	0.00075643	0.03761955925924404
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.03761955925924404
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02713205588371379
AARSKOG-SCOTT SYNDROME	0.000545554	0.02713205588371379
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02713205588371379
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02713205588371379
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.02713205588371379
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02713205588371379
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000545554	0.02713205588371379
AUSTRALIA ANTIGEN	0.000545554	0.02713205588371379
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.02713205588371379
HURLER SYNDROME	0.000545554	0.02713205588371379
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02713205588371379
PETTIGREW SYNDROME	0.000545554	0.02713205588371379
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02713205588371379
CODAS SYNDROME	0.000545554	0.02713205588371379
POTOCKI-SHAFFER SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.02713205588371379
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02713205588371379
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02713205588371379
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.02713205588371379
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02713205588371379
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02713205588371379
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02713205588371379
MEND SYNDROME; MEND	0.000545554	0.02713205588371379
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02713205588371379
MONOSOMY 22Q13.3	0.000545554	0.02713205588371379
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
CURRARINO SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.02713205588371379
PRADER-WILLI SYNDROME; PWS	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02713205588371379
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02713205588371379
PFEIFFER SYNDROME TYPE 2	0.000545554	0.02713205588371379
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02713205588371379
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02713205588371379
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02713205588371379
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000545554	0.02713205588371379
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.02713205588371379
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02713205588371379
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.02713205588371379
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
INCONTINENTIA PIGMENTI	0.000545554	0.02713205588371379
DIGEORGE SYNDROME; DGS	0.000545554	0.02713205588371379
TARP SYNDROME; TARPS	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.02713205588371379
CHAR SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000545554	0.02713205588371379
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.02713205588371379
48,XYYY SYNDROME	0.000545554	0.02713205588371379
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02713205588371379
TRANSKETOLASE DEFICIENCY	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
XQ25 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.02713205588371379
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.02713205588371379
KRABBE DISEASE	0.000545554	0.02713205588371379
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02713205588371379
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.02713205588371379
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.02713205588371379
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02713205588371379
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.02713205588371379
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02713205588371379
THYROID HYPOPLASIA	0.000545554	0.02713205588371379
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000545554	0.02713205588371379
PELLAGRA-LIKE SYNDROME	0.000545554	0.02713205588371379
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.02713205588371379
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02713205588371379
PALLISTER-HALL SYNDROME	0.000545554	0.02713205588371379
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.02713205588371379
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02713205588371379
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.02713205588371379
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.02713205588371379
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.02713205588371379
X SMALL RINGS	0.000545554	0.02713205588371379
OROTIC ACIDURIA	0.000545554	0.02713205588371379
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02713205588371379
PALLISTER-HALL SYNDROME	0.000545554	0.02713205588371379
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02713205588371379
HYPERPROLINEMIA, TYPE I	0.000545554	0.02713205588371379
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02713205588371379
PMM2-CDG	0.000545554	0.02713205588371379
ALG6-CDG	0.000545554	0.02713205588371379
3MC SYNDROME 2	0.000545554	0.02713205588371379
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.02713205588371379
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.02713205588371379
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02713205588371379
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02713205588371379
RIGID SPINE SYNDROME	0.000545554	0.02713205588371379
NARP SYNDROME	0.000545554	0.02713205588371379
GAUCHER DISEASE, TYPE II	0.000545554	0.02713205588371379
ZEBRA BODY MYOPATHY	0.000545554	0.02713205588371379
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02713205588371379
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02713205588371379
HARTNUP DISORDER	0.000545554	0.02713205588371379
THYROID HEMIAGENESIS	0.000545554	0.02713205588371379
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02713205588371379
LEBER CONGENITAL AMAUROSIS	0.000545554	0.02713205588371379
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02713205588371379
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.02713205588371379
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.02713205588371379
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.02713205588371379
ARIMA SYNDROME	0.000545554	0.02713205588371379
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.02713205588371379
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02713205588371379
WOLMAN DISEASE	0.000545554	0.02713205588371379
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.02713205588371379
KETOADIPICACIDURIA	0.000545554	0.02713205588371379
RECOMBINANT 8 SYNDROME	0.000545554	0.02713205588371379
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02713205588371379
3C SYNDROME	0.000545554	0.02713205588371379
LANDAU-KLEFFNER SYNDROME	0.000545554	0.02713205588371379
MONOSOMY 9Q22.3	0.000545554	0.02713205588371379
6Q TERMINAL DELETION SYNDROME	0.000545554	0.02713205588371379
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02713205588371379
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.02713205588371379
INFANTILE REFSUM DISEASE	0.000545554	0.02713205588371379
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02713205588371379
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.02713205588371379
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.02713205588371379
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000545554	0.02713205588371379
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.02713205588371379
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02713205588371379
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02713205588371379
ELEJALDE DISEASE	0.000545554	0.02713205588371379
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.02713205588371379
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02713205588371379
SEPTOOPTIC DYSPLASIA	0.000545554	0.02713205588371379
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02713205588371379
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.02713205588371379
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.02713205588371379
DISTAL MONOSOMY 6P	0.000545554	0.02713205588371379
DISTAL MONOSOMY 19P13.3	0.000545554	0.02713205588371379
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.02713205588371379
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.02713205588371379
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02713205588371379
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02713205588371379
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02713205588371379
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.02713205588371379
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.02713205588371379
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02713205588371379
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.02713205588371379
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.02713205588371379
CHAR SYNDROME	0.000545554	0.02713205588371379
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.02713205588371379
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.02713205588371379
MAPLE SYRUP URINE DISEASE	0.000545554	0.02713205588371379
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.02713205588371379
XQ25 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
KEUTEL SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.02713205588371379
300270 ADRENOMYODYSTROPHY	0.000545554	0.02713205588371379
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.02713205588371379
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 10	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.02713205588371379
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.02713205588371379
TREACHER-COLLINS SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.02713205588371379
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.02713205588371379
FRIED SYNDROME	0.000545554	0.02713205588371379
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.02713205588371379
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.02713205588371379
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02713205588371379
JOUBERT SYNDROME 1	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.02713205588371379
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02713205588371379
SCHIZENCEPHALY	0.000545554	0.02713205588371379
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02713205588371379
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.02713205588371379
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02713205588371379
THYROID ECTOPIA	0.000545554	0.02713205588371379
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.02713205588371379
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.02713205588371379
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.02713205588371379
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.02713205588371379
COACH SYNDROME	0.000545554	0.02713205588371379
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.02713205588371379
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000545554	0.02713205588371379
ATHYREOSIS	0.000545554	0.02713205588371379
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02713205588371379
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02713205588371379
ALPHA-MANNOSIDOSIS	0.000545554	0.02713205588371379
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02713205588371379
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02713205588371379
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.02713205588371379
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02713205588371379
ATELOSTEOGENESIS TYPE III	0.000545554	0.02713205588371379
WEAVER SYNDROME	0.000545554	0.02713205588371379
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02713205588371379
TAY-SACHS DISEASE	0.000545554	0.02713205588371379
SYNDROMIC DIARRHEA	0.000545554	0.02713205588371379
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02713205588371379
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02713205588371379
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME VI	0.000545554	0.02713205588371379
WYBURN-MASON SYNDROME	0.000545554	0.02713205588371379
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02713205588371379
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02713205588371379
CRANIOPHARYNGIOMA	0.000545554	0.02713205588371379
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02713205588371379
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02713205588371379
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.02713205588371379
FG SYNDROME TYPE 1	0.000545554	0.02713205588371379
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.02713205588371379
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02713205588371379
DESANTO-SHINAWI SYNDROME	0.000545554	0.02713205588371379
COLE-CARPENTER SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.02713205588371379
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02713205588371379
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.02713205588371379
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.02713205588371379
GERMAN SYNDROME	0.000545554	0.02713205588371379
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02713205588371379
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.02713205588371379
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000545554	0.02713205588371379
OPTIC PATHWAY GLIOMA	0.000545554	0.02713205588371379
EVEN-PLUS SYNDROME	0.000545554	0.02713205588371379
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.02713205588371379
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.02713205588371379
HARTNUP DISEASE	0.000545554	0.02713205588371379
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02713205588371379
LAMB-SHAFFER SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.02713205588371379
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.02713205588371379
DONNAI-BARROW SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 26	0.000545554	0.02713205588371379
JOUBERT SYNDROME 25	0.000545554	0.02713205588371379
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.02713205588371379
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.02713205588371379
ZECHI-CEIDE SYNDROME	0.000545554	0.02713205588371379
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02713205588371379
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.02713205588371379
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02713205588371379
FLOATING-HARBOR SYNDROME	0.000545554	0.02713205588371379
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.02713205588371379
DISTAL TRISOMY 18Q	0.000545554	0.02713205588371379
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.02713205588371379
ZTTK SYNDROME; ZTTKS	0.000545554	0.02713205588371379
JOUBERT SYNDROME 28	0.000545554	0.02713205588371379
JOUBERT SYNDROME 27	0.000545554	0.02713205588371379
DISTAL TRISOMY 6P	0.000545554	0.02713205588371379
TRISOMY 8Q	0.000545554	0.02713205588371379
DYSKERATOSIS CONGENITA	0.000545554	0.02713205588371379
TEMTAMY SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.02713205588371379
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.02713205588371379
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.02713205588371379
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.02713205588371379
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.02713205588371379
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.02713205588371379
OCCIPITAL HORN SYNDROME	0.000545554	0.02713205588371379
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02713205588371379
EAST SYNDROME	0.000545554	0.02713205588371379
COWDEN SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.02713205588371379
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02713205588371379
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.02713205588371379
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02713205588371379
TRISOMY 12P	0.000545554	0.02713205588371379
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02713205588371379
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02713205588371379
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.02713205588371379
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02713205588371379
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.02713205588371379
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.02713205588371379
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.02713205588371379
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02713205588371379
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.02713205588371379
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02713205588371379
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02713205588371379
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.02713205588371379
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.02713205588371379
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 2	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.02713205588371379
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02713205588371379
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.02713205588371379
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02713205588371379
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02713205588371379
JOUBERT SYNDROME 24	0.000545554	0.02713205588371379
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02713205588371379
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.02713205588371379
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02713205588371379
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02713205588371379
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02713205588371379
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02713205588371379
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.02713205588371379
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.02713205588371379
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02713205588371379
ICF SYNDROME	0.000545554	0.02713205588371379
AU-KLINE SYNDROME; AUKS	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000545554	0.02713205588371379
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
NOONAN SYNDROME 9; NS9	0.000545554	0.02713205588371379
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02713205588371379
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02713205588371379
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02713205588371379
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.02713205588371379
USHER SYNDROME TYPE 1	0.000545554	0.02713205588371379
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.02713205588371379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.02713205588371379
CHOPS SYNDROME; CHOPS	0.000545554	0.02713205588371379
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02713205588371379
MOSAIC TRISOMY 14	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.02713205588371379
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.02713205588371379
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000545554	0.02713205588371379
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02713205588371379
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.02713205588371379
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.02713205588371379
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.02713205588371379
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.02713205588371379
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000545554	0.02713205588371379
NOONAN SYNDROME 11; NS11	0.000545554	0.02713205588371379
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000545554	0.02713205588371379
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02713205588371379
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02713205588371379
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.02713205588371379
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02713205588371379
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02713205588371379
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.02713205588371379
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.02713205588371379
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.02713205588371379
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.02713205588371379
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.02713205588371379
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000545554	0.02713205588371379
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.02713205588371379
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02713205588371379
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.02713205588371379
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.02713205588371379
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.02713205588371379
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000545554	0.02713205588371379
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.02713205588371379
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.02713205588371379
TRANSALDOLASE DEFICIENCY	0.000545554	0.02713205588371379
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02713205588371379
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000545554	0.02713205588371379
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.02713205588371379
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02713205588371379
CANAVAN DISEASE	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02713205588371379
XQ21 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
CINCA SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.02713205588371379
CODAS SYNDROME	0.000545554	0.02713205588371379
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02713205588371379
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.02713205588371379
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.02713205588371379
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000545554	0.02713205588371379
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02713205588371379
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.02713205588371379
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.02713205588371379
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.02713205588371379
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.02713205588371379
DISTAL MONOSOMY 9P	0.000545554	0.02713205588371379
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.02713205588371379
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.02713205588371379
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.02713205588371379
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02713205588371379
DEXTROCARDIA	0.000545554	0.02713205588371379
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.02713205588371379
AURICULOCONDYLAR SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.02713205588371379
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.02713205588371379
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.02713205588371379
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.02713205588371379
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.02713205588371379
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.02713205588371379
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.02713205588371379
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.02713205588371379
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.02713205588371379
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.02713205588371379
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.02713205588371379
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.02713205588371379
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02713205588371379
AYMÉ-GRIPP SYNDROME	0.000545554	0.02713205588371379
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02713205588371379
MECKEL SYNDROME 13; MKS13	0.000545554	0.02713205588371379
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.02713205588371379
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02713205588371379
RAHMAN SYNDROME	0.000545554	0.02713205588371379
CARDIOFACIOCUTANEOUS SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.02713205588371379
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.02713205588371379
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.02713205588371379
CULLER-JONES SYNDROME; CJS	0.000545554	0.02713205588371379
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.02713205588371379
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02713205588371379
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.02713205588371379
WILSON-TURNER SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02713205588371379
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.02713205588371379
FUCOSIDOSIS	0.000545554	0.02713205588371379
ISOLATED PLAGIOCEPHALY	0.000545554	0.02713205588371379
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02713205588371379
JOUBERT SYNDROME 7	0.000545554	0.02713205588371379
NOONAN SYNDROME 5; NS5	0.000545554	0.02713205588371379
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.02713205588371379
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.02713205588371379
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02713205588371379
HOLOPROSENCEPHALY 7	0.000545554	0.02713205588371379
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.02713205588371379
JOUBERT SYNDROME 6	0.000545554	0.02713205588371379
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02713205588371379
19P13.13 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02713205588371379
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02713205588371379
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.02713205588371379
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.02713205588371379
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.02713205588371379
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02713205588371379
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.000545554	0.02713205588371379
NOONAN SYNDROME 3; NS3	0.000545554	0.02713205588371379
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.02713205588371379
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.000545554	0.02713205588371379
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02713205588371379
WEAVER SYNDROME	0.000545554	0.02713205588371379
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.02713205588371379
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02713205588371379
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02713205588371379
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02713205588371379
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.02713205588371379
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.02713205588371379
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02713205588371379
SRD5A3-CDG	0.000545554	0.02713205588371379
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.02713205588371379
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02713205588371379
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.02713205588371379
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.02713205588371379
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02713205588371379
TETRASOMY 5P	0.000545554	0.02713205588371379
TETRASOMY 9P	0.000545554	0.02713205588371379
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02713205588371379
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.02713205588371379
FARBER DISEASE	0.000545554	0.02713205588371379
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.02713205588371379
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 8	0.000545554	0.02713205588371379
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02713205588371379
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02713205588371379
FRIAS SYNDROME	0.000545554	0.02713205588371379
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.02713205588371379
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.02713205588371379
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02713205588371379
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.02713205588371379
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02713205588371379
FRONTOOCULAR SYNDROME	0.000545554	0.02713205588371379
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02713205588371379
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.02713205588371379
DYSTONIA-APHONIA SYNDROME	0.000545554	0.02713205588371379
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02713205588371379
NOONAN SYNDROME 2; NS2	0.000545554	0.02713205588371379
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02713205588371379
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000545554	0.02713205588371379
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.02713205588371379
CDAGS SYNDROME	0.000545554	0.02713205588371379
MUENKE SYNDROME	0.000545554	0.02713205588371379
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02713205588371379
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.02713205588371379
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.02713205588371379
CURRY-JONES SYNDROME	0.000545554	0.02713205588371379
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.02713205588371379
CONGENITAL HYPOTHYROIDISM	0.000545554	0.02713205588371379
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.02713205588371379
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02713205588371379
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.02713205588371379
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.02713205588371379
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.02713205588371379
PHACE ASSOCIATION	0.000545554	0.02713205588371379
MEND SYNDROME	0.000545554	0.02713205588371379
KAGAMI-OGATA SYNDROME	0.000545554	0.02713205588371379
SCHINDLER DISEASE, TYPE I	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.02713205588371379
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.000545554	0.02713205588371379
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000545554	0.02713205588371379
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02713205588371379
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.02713205588371379
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.02713205588371379
GRISCELLI SYNDROME	0.000545554	0.02713205588371379
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02713205588371379
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02713205588371379
JOUBERT SYNDROME 2	0.000545554	0.02713205588371379
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02713205588371379
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.02713205588371379
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.02713205588371379
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.02713205588371379
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.02713205588371379
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02713205588371379
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.02713205588371379
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02713205588371379
HURLER SYNDROME	0.000545554	0.02713205588371379
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.02713205588371379
NOONAN SYNDROME 6; NS6	0.000545554	0.02713205588371379
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.02713205588371379
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.02713205588371379
BILATERAL POLYMICROGYRIA	0.000545554	0.02713205588371379
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02713205588371379
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.02713205588371379
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.02713205588371379
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02713205588371379
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02713205588371379
OPITZ G/BBB SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.02713205588371379
STEEL SYNDROME; STLS	0.000545554	0.02713205588371379
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02713205588371379
L1 SYNDROME	0.000545554	0.02713205588371379
TYSHCHENKO SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.02713205588371379
OGDEN SYNDROME	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02713205588371379
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02713205588371379
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.02713205588371379
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02713205588371379
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02713205588371379
LATERAL MENINGOCELE SYNDROME	0.000545554	0.02713205588371379
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02713205588371379
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.02713205588371379
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02713205588371379
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000545554	0.02713205588371379
JOUBERT SYNDROME 21	0.000545554	0.02713205588371379
XIA-GIBBS SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02713205588371379
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.02713205588371379
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02713205588371379
N SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.02713205588371379
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.02713205588371379
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.02713205588371379
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
17Q12 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
20P12.3 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.02713205588371379
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.02713205588371379
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02713205588371379
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.02713205588371379
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02713205588371379
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02713205588371379
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.02713205588371379
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.02713205588371379
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02713205588371379
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02713205588371379
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02713205588371379
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.02713205588371379
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.02713205588371379
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000545554	0.02713205588371379
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02713205588371379
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02713205588371379
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000545554	0.02713205588371379
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.02713205588371379
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.02713205588371379
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.02713205588371379
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02713205588371379
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
SEVERE CANAVAN DISEASE	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.02713205588371379
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.02713205588371379
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02713205588371379
SIALURIA	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.02713205588371379
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.02713205588371379
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02713205588371379
W SYNDROME	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02713205588371379
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.02713205588371379
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.02713205588371379
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.02713205588371379
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.02713205588371379
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02713205588371379
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02713205588371379
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.02713205588371379
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.02713205588371379
PERLMAN SYNDROME	0.000545554	0.02713205588371379
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.02713205588371379
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.02713205588371379
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.02713205588371379
TARP SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 15	0.000545554	0.02713205588371379
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 14	0.000545554	0.02713205588371379
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.02713205588371379
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000545554	0.02713205588371379
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02713205588371379
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02713205588371379
SENIOR-LOKEN SYNDROME	0.000545554	0.02713205588371379
